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CHAPTER 1 
 
INTRODUCTION AND SIGNIFICANCE 
 
Scientific evidence supports that the nutritional and immunogenic properties of human 
milk improve health outcomes for infants worldwide. Despite this evidence, many mothers are 
not aware of the specific science of how human milk supports infant health. In fact, many 
women perceive that their milk does not satisfy their infant, does not promote adequate growth, 
or they misinterpret formula supplementation in the hospital as a signal that their milk is inferior 
to formula (Chantry et al., 2014; Odom et al., 2013). Identification of the immunologic 
properties of breastmilk that contribute to infant health may encourage more women to choose 
and sustain breastfeeding through their infants’ first year of life. Maternal education should 
include the evidence that milk is not just nutrition but it is the best medicine for infant health. 
Historically it has been reported that infants who were breastfed by women stressed by living in 
natural disasters or war-zones not only survive but are less vulnerable to disease than formula fed 
infants where sanitation and supplies formula preparation may be limited (World Health 
Organization, 2002; Shaker Berbari, 2013). Clearly, bringing the science of the immunogenic 
protective properties of breastmilk to the women making feeding choice decisions for their 
infants is needed to improve infant population health.  
The abundant protective properties of human milk are recognized worldwide.  The World 
Health Organization recommends that breastfeeding is the optimal source of nutrition for infants 
during emergent crises (war or natural disasters) or maternal HIV infection (2007). The 
protective properties of milk consist of numerous immune components that function to instruct 
the infant intestinal components how to respond to both beneficial organisms and pathogens 
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(Agarwal, Karmaus, Davis & Gangur, 2011; Lawrence & Pane, 2007). These immune 
components are also associated with a reduction in the incidence of immune mediated diseases 
among breastfed infants not only during infancy but extending on to childhood and adulthood 
(Field, 2005). Breastfed infants in developed as well as under-developed countries have a 
decreased incidence of infection and allergies during the first 12 months of life (Labbock, Clark, 
& Goldman, 2004). The evidence is strong that breastmilk promotes and sustains infant health. 
The consumption of human milk is also associated with a decrease in health-care 
expenditures due to the lower incidence of hospital acquired infections in infants (Bisquera, 
Cooper, & Berseth, 2002; Leroyer et al, 1997; Rodriguez et al., 2005; Wall, 2007). Cost savings 
from the reduction of infant illness post discharge of those receiving human milk is estimated to 
be $475/infant during the first six months of life, generating a savings of $3.6 billion/year in 
federal expenditures on healthcare (Wall, 2007). With the ongoing increase in healthcare 
expenditures it is now estimated that over $13 billion/year could be saved if 90% of mothers 
breastfed their infants exclusively for 6 months (Bartick & Rienhold, 2010).  
Globally, human milk is associated with a reduction in infant mortality through the 
decreased incidence of respiratory and gastrointestinal disease (Arifeen, Black, Antelman, Baqui, 
Caulfield, & Becker, 2001; Labbock et al., 2004). In the US, there is a disparity in infant health 
outcomes associated with race. African American (AA) infants have the highest percentages of 
mortality during the first year of life related to low birth weight, <2500 grams, (AA=13.75% vs. 
non-Hispanic White =7.2%) and sudden infant death syndrome (AA=87% higher than non-
Hispanic Whites (Centers for Disease Control and Prevention, 2013a). Very low birth weight 
infants(<2500grams)  that are breastfed reach optimal growth and development within the first 
year of life; however, AA mothers have the lowest breastfeeding initiation rates regardless of 
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education and socioeconomic background which places the AA infants at a significant 
disadvantage (Centers for Disease Control and Prevention, 2012a; Ludington-Hoe, McDonald, & 
Satyshur, 2002; March of Dimes, 2010).  
Historically, AA women were at risk for health disparities due to limited access to health 
care; however, recent evidence suggests that chronic stress may also play a role in health 
disparities such as hypertension, diabetes and adverse birth outcomes within this population 
(Hicken, Lee, Morenoff, House & Williams, 2014; Wallace & Harville, 2012). Stressors such as 
lower socioeconomic status are associated with health disparities. Many women of lower 
socioeconomic status are enrolled in Medicaid for healthcare. In 2010, nearly 48 % of all US 
births were supported by Medicaid (Kaiser Family Foundation, 2010; March of Dimes, 2009; 
Markus, Adres, West, Garro, & Pellegrini, 2013). Also in 2010, states such as Louisiana reported 
that 69 % of all births were supported by Medicaid and > 90% of these mothers were asked by 
their healthcare providers to provide breastmilk because scientific evidence supports that 
breastfeeding is the optimal feeding choice (Markus et al., 2013; U S Department of Health and 
Hospitals, 2010).  Knowing that prenatal conditions such as socioeconomic status are likely to 
continue post-delivery it is not known whether maternal stressful conditions alter milk immune 
components. The evidence to date supports that breastmilk protects the infant regardless of 
maternal conditions (World Health Organization, 2002; Shaker-Berbari, 2013); however little is 
known about whether there are immunological changes in breastmilk as a result of maternal 
stress. 
Very little empirical data is available to assess the immunogenic properties of human 
milk among women who experience stress. Additionally, no research to date has examined the 
association between maternal self-perceived stress and milk immune components among AA 
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mothers; a population that experiences a higher percentage of immune mediated diseases 
(diabetes and hypertension) and mortality (Centers for Disease Control and Prevention, 2010; 
Office on Women's Health, 2013). Therefore, the purpose of this study is to explore the 
relationship between maternal stress and breastmilk immune components among AA women 
during the first 14 days post-delivery. Gathering this information could lead to effective 
interventions that reduce stress and decrease health disparities associated with stress for AA 
women and their children. Given there is a gap in health disparities for minorities such as AA, 
the immune components in breastmilk holds the potential to significantly improve population 
health for AA infants (Agarwal et al., 2011; Labbock et al., 2004). 
 
Specific Aims and Research Hypotheses 
 The specific aims and hypotheses of this study include the following:  
1. Assess the associations of maternal stress indicators with specific milk immune components 
(antibodies, cytokines, and chemokines) from AA mothers of term infants during the first 14 
days post-delivery.  
H0 1 There will be no statistically significant simultaneous (within each collection day) or cross-
lagged associations (from Day 3- Day 14) of maternal stress indicators with levels of milk 
immune components (antibodies, cytokines, and chemokines) post- delivery.   
2. Assess the mediation (indirect) effect of maternal cortisol on the direct association of 
maternal stress indicators and milk immune components (antibodies, cytokines, and 
chemokines) from AA mothers of term infants.  
H0 2 There will be no statistically significant mediation (indirect) effect of cortisol on the milk 
immune components (antibodies, cytokines, and chemokines). 
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 Maternal stress indicators for Aim 1 were defined as physical (age, race, number of 
previous pregnancies, mode of delivery, smoking, infection, hypertension, diabetes), 
psychological (summed scores of the Perceived Stress Scale which measures the degree in which 
situations are perceived as unpredictable and burdensome during the past days/weeks/months), 
and environmental (socioeconomic status, number of children cared for, relationship status). 
Maternal Stress Indicators for Aim 2 were defined as the summed scored of the Perceived Stress 
Scale on Day 3, and salivary cortisol on Day 9. Breastmilk immune components that were 
measured were chosen for their contribution to infant health: antibodies-secretory 
Immunoglobulin A (SIgA), cytokines/chemokines and growth factors-epithelial growth factor 
(EGF), interleukins 4,6,8, and 10 (IL-4, IL-6, IL-8, Il-10), tumor necrosis factor-alpha (TNF-α), 
interferon gamma-induced protein 10 (IP-10), monocyte chemotactic protein-1 (MCP-1), and 
macrophage inflammatory protein (MIP-1α). The biomarker, salivary cortisol, was chosen as a 
mediating variable that may have an indirect effect on the direct associations of maternal stress 
indicators with breastmilk immune components. See Figure 1 below for a summary of the 
proposed cortisol mediation pathway.   
 
 
 
 
Figure 1. Cortisol Mediation Pathway on Direct Associations of Maternal Stress Indicators With 
Milk Immune Components 
 
 
Maternal Stress  
Salivary Cortisol 
Breastmilk Immune 
Components 
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CHAPTER 2 
 
THEORETICAL FRAMEWORK AND LITERATURE REVIEW 
 
Theoretical Framework 
 
Early definitions of stress focused only on the physiology of the stress response (Seyle, 
1976). Later, Borysenko (1987) proposed that psychological stressors moderate the homeostasis 
of the immune system beginning the science now known as psycho-neuro-endocrine-
immunology (PNI). Ader, Cohen & Felten (1995) continued to refine the PNI theory by 
describing the mechanisms of interactions between the neuro-endocrine immune systems 
including the actions of neuro-endocrine mediators on cellular immune changes.  
Psychological self-perceived stress, defined by Lazarus and Folkman (1984), is the 
cognitive processes used to appraise and classify the stress in relation to the significance to the 
self.  To further understand the relationship between self-perceived stress and immunity, research 
has focused on how the stressor is processed using cognitive perception and inter-related 
activation of the  nervous, endocrine and immune systems (Rice, 2000). For mothers post-
delivery there are numerous stressors that influence maternal self-perceived stress. These 
stressors post-delivery are described as arising from within the maternal-infant dyad (maternal/ 
infant health, role ambiguity) and external to the mother-infant dyad (socioeconomic issues, 
family issues, work/school) (Jevitt, Groer , Crist, Gonzales, & Wagner, 2012). During this 
stressful time, the maternal neuro-endocrine-immune systems work to promote healing in the 
mother and also provide the immune protective properties in the breastmilk.   
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Both the PNI framework (Ader et al., 1995) and the Lazarus and Folkman stress and 
coping framework (1984) contain concepts that can be used to describe the relationships between 
maternal perceived stress, milk immune components and their infant outcomes (Lyon, 2000). 
Relevant concepts from each of these frameworks were selected to guide the proposed study. 
Logical linkages among these concepts were used to develop the new proposed conceptual 
model which presents the inter-relationships of the theories of PNI and Lazarus & Folkman 
(1984). The concepts that are shadowed will not be explored at this time due to feasibility issues 
and scope of this dissertation but they remain relevant for future research.  
                                                                                                                                             
                                                                                                                                                                                       
 
 
       
                                                                                                                                                                   
                                                                                                                                                                                                                                                         
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Post-Delivery Human Milk Model 
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psychological- perceived stress; and environmental- socioeconomic status, relationship status, 
number of children cared for at home) influences the bio-behavioral stress response in the mother 
which may alter the protective immune components in breastmilk and in turn influence infant 
outcomes. The Post-delivery Human Milk model incorporates the interaction of neuro-
endocrine-immune systems that potentially mediate the stress response. Understanding the 
direction of these proposed concepts will lead to the development of healthcare interventions to 
support the quality of human milk and infant outcomes. 
 
Literature Review 
Maternal Stress, Immunity, and Infant Outcomes 
 The definition of stress in the literature is multi-dimensional; physical stress, 
psychological stress, and the duration of stress.  In stress-immune research, the duration of stress 
(physical or psychological) is associated with alterations in the immune response (Segerstrom & 
Miller, 2004). Acute psychological and physical stress can be time limited in the laboratory 
(mental exams, exercise), naturalistic (real time stressful situations such as delivery of an infant), 
or sequence events (loss of a loved one, job loss). Chronic stress, however, has no defined time 
limit or sequence. Science suggests that it is the instability of the time element in chronic stress 
that leads to life-altering changes in personal health and behaviors (Kiekolt-Glaser, Preacher, 
MacCallum, Atkinson, Malarkey & Glaser, 2003; Segerstrom & Miller, 2004). Examples of 
chronic stress include physical disabilities, the caretaker role (mother), socioeconomic burdens, 
living in high crime neighborhoods, or living in areas struck by natural disasters (Beckie, 2012; 
Callaghan et al., 2007; Cohen, Doyle, & Baum, 2006; Kiekolt-Glaser et al., 2003; Segerstrom & 
Miller, 2004).  
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Stress and Immunity Overview  
How stress influences the immune system is complex; the specific pathways between 
stress and the immune system are still being discovered (Segerstrom & Miller, 2004). Stress 
initially stimulates the sympathetic nervous system fibers that reach from the brain to the bone 
marrow and lymphoid tissues. This first reaction to stress stimuli induces changes on the 
receptors of white blood components which in turn creates a cascade of immune cell activities. If 
the stress is ongoing, the hypothalamic-pituitary-adrenal cortex (HPA) axis results in the 
secretion of cortisol.  Other endocrine products released in stress include epinephrine, 
norepinephrine, melatonin, and prolactin. These hormones bind to receptors on white blood cells 
to regulate white blood cell function and distribution.  The elasticity of the stress immune 
response is variable and can be influenced by vulnerabilities (age, prior disease states, and 
autoimmune states) and duration of the stressors.  
The immune response can be categorized as either innate immunity or acquired immunity 
(Janeway, Travers, Walport & Shlomchik, 2005; Segerstrom & Miller, 2004). Innate immunity is 
a swift immune response that does not provide a defense against a specific pathogen and it is 
characterized by inflammation (Segerstrom & Miller, 2004). During this response, the white 
blood cells (neutrophils and macrophages) rush to the site of injury to release toxic substances 
that damage the pathogen invader, and then destroy by engulfing the invader. Macrophages 
release cytokines which are the communicators of the immune system. Cytokines stimulate pro-
inflammatory and anti-inflammatory responses and a balance is needed to protect the tissues 
from self-destruction. Acquired immunity is less rapid but it is a more targeted immune response 
using white blood cells known as lymphocytes with specific receptors on the cell surface that 
have affinity to the antigens on the pathogen invader. One lymphocyte called the T-helper cell 
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also produces cytokines that can augment the acquired immune response. Another lymphocyte 
type, B-cells, produce antibodies that can destroy the pathogen complex with antigenic toxins, 
bind to viruses to prevent their entry into the host cells, or coat the host cells with protection. 
In a meta-analysis of 30 years of stress immune research the immune responses to acute 
and chronic stress were reviewed (Segerstrom & Miller, 2004). Time limited stress such as acute 
and sequence events induce the flight or fright immune response which increases the production 
of cytokines and antibodies across the immune system. Conversely, chronic stress is associated 
with a decrease or alteration of the immune cell distribution and function. With chronic stress 
there can be a shift in the balance of cytokines as well as a decrease in the amount of cytokines 
and lymphocytes produced which increases the vulnerability of the host to disease (Elenkov, 
2004). In human milk there is a balance of immune components designed to protect the infant 
(Garofalo, 2010; Goldman, 2007). These components are produced by mammary gland cells, 
mammary epithelium, or may diffuse from maternal serum across the mammary epithelium. The 
concentrations of the immune components in milk do not match those present in maternal serum 
suggesting that the mammary gland itself is the primary origin of most milk immune components 
(Agarwal, Karmaus, Davis & Gangur, 2011). Thus, it is not known whether the maternal stress 
response can influence immune cell changes in human milk.   
Stress, Cortisol, and Immunity  
The balance of the body’s immune response to stress is influenced by glucocorticoid 
neuroendocrine hormones such as cortisol (Elenkov, 2004). It was originally thought that cortisol 
inhibited the production and function of immune cells but more current evidence indicates that 
cortisol selectively influences immune cell response creating a shift in the specific immune 
response. The two arms of the specific immune response are Th1 cells which provide immunity 
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within the cellular components and Th2 cells which provide immunity outside of the cellular 
components. Cytokines that play a role in Th1 immunity include interleukin-2 interferon-gamma, 
and tumor necrosis factor-alpha; whereas, cytokines that play a role in Th2 immunity include 
interleukins-4, 5, 9, 10 and 13 (Elenkov, 2004; Janeway et al., 2005). Cortisol is associated with 
a decrease in Th1 cells leading to susceptibility to infection and or illness symptoms (Elenkov, 
2004).    
 Elevated corticoid states such as pregnancy directly influence a shift in the Th1/Th2 ratio 
of maternal immunity (Ruiz & Avant, 2005). During pregnancy, there is a suppression of Th1 
cells but it is felt this suppression is needed to prevent the maternal rejection of the fetus. Both 
the maternal circulating cortisol and the placental produced cortisol are necessary for fetus 
growth and development and play a role in the immune cell shift that protects the fetus. With 
each additional week of gestation there is a 3.6% increase in cortisol (Giesbrecht, Campbell, 
Letourneau, Kooistra, & Kaplan, 2012). The rise in cortisol is thought to provide the necessary 
energy for fetal growth and also support the mother during labor and delivery (Ruiz & Avant, 
2005). Post-delivery, there is a natural decline of the cortisol levels reaching pre-pregnancy 
levels between 1-2 weeks post-delivery (O'Keane et al., 2011).  With the decline of cortisol post-
delivery there is an increase in serum Th1 cells to pre-pregnancy levels (Ruiz & Avant, 2005).  
Maternal cortisol levels can increase with stress pre and post-delivery. In a randomized 
controlled trial of 61 pregnant women with self-reports of anxiety, those not receiving the 
supportive intervention had significantly greater salivary cortisol levels at 3 months post-delivery 
than mothers who received support (Area Under the Curve [AUC] = 32.7 ng/mL versus 
AUC=27.8 ng/mL, p<0.001) (Richter et al., 2012).  Similarly, maternal self-report of stress post-
delivery is associated with increased salivary cortisol levels for up to 6 months post-delivery. 
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Urizar and Munoz (2011) reported higher salivary morning cortisol in low-income mothers 
(n=24) versus low risk mothers (n=22) at 6 months post-delivery (9.3 ±2.3 ng/mL [95% CI= 8.4, 
10.4] versus 8.3 ± 4 ng/mL [95% CI= 6.8, 10.1], p< 0.050).  Among lactating women, those with 
previous pregnancies had greater levels of salivary cortisol on day 14 post-delivery than those 
mothers pregnant for the first  time (3.4 ±0 .9 ng/mL [95% CI= 3.0,3.1] versus 3.2 ± .8 ng/mL 
[95% CI= 2.9, 3.5]) but these differences were not significant (Kawano, Emori, & Miyagawa, 
2009). Normative salivary cortisol values for 43 women < 14 days post-delivery collected at 
noon (±2 hours) were 4.61± .03 ng/mL(95% CI= 4.6, 4.62) (Hampson, Phillips, Soares, & 
Steiner, 2013). Feeding status was not reported by Hampson and colleagues (2013), thus we do 
not know if the ranges of salivary cortisol between < 14 days post-delivery and day 14 post-
delivery are related to lactation or the timing of the saliva collections (Hampson et al., 2013; 
Kawano et al., 2009).  
There is, however, limited research suggesting that lactation is associated with lower 
salivary cortisol levels in women post-delivery.  Tu and colleagues, (2006a), explored salivary 
cortisol 5-20 weeks post-delivery among 24 breastfeeding and 24 bottle feeding primiparous and 
multiparous women. The breastfeeding women had significantly lower awake cortisol levels than 
bottle feeding women across all days of collections (breastfeeding =1.7- 1.8 ng/mL versus bottle 
feeding= 1.8- 3.2 ng/mL, p <0 .050). However, the lowered cortisol observed in lactating women 
may be short-lived. In a randomized control trail of 43 lactating women 8 weeks post-delivery, 
post-intervention salivary cortisol was lower in women who breastfed 15 minutes prior (n=20) to 
a brief psychosocial stressor versus those instructed to just hold their infant (n=23) (breastfed 
=2.57 ± .18 ng/mL [95% CI= 1.8, 3.3] versus held infant = 2.61±.25 ng/mL [95% CI=2.5, 2.7], 
p=0.006) (Heinrichs et al., 2001). Even though the decreased response to stress among lactating 
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women appears to be time limited, both animal and human research describe a reduction in the 
stress response to both physical and psychological stressors among lactating mothers (Heinrichs, 
Neumann & Ehlert, 2002).  
The use of salivary cortisol has a number of advantages over serum cortisol in health 
research (Kirschbaum & Hellhammer, 2000). Salivary cortisol levels rise more quickly than 
serum cortisol after a perceived psychological and/or physical stressor such as caring for a 
newborn post-delivery and salivary cortisol levels return to baseline faster than serum cortisol 
(Nicholson, 2008). Salivary cortisol is more feasible in field research for it is relatively easy for 
the participant to collect and remains stable at room temperature (Kirschbaum & Hellhammer, 
2000). In health research, a standard method to measure salivary cortisol is the cortisol 
awakening response (CAR) where saliva is collected upon awakening, 30 minutes after waking 
and 45-60 minutes after waking (Fekedulegn et al., 2007). The multiple measures can be 
transformed into a single measure called area under the curve (AUC) and used to correlate with 
psychometric instruments. Correlations of salivary cortisol with psychometric instruments are 
difficult to trend across studies due to the timing of cortisol collections and the confounding 
variables that may reduce stress such as social support.  In a large cohort of 1,587 pregnant 
women, the Perceived Stress Scale (PSS) summed scores correlated weakly with morning 
salivary cortisol at 24-29 weeks gestation (r=0.07, p<0.050) (Harville et al., 2009). A major 
limitation of this study was the lack of standardization of the timing of the salivary cortisol 
collections. Salivary cortisol is an isolated measurement of stress post-delivery. Consideration 
should be given to also measure other known stressors such as self-perceived stress, and 
maternal characteristics to clearly define maternal stress post-delivery.   
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The Perceived Stress Scale (PSS) which measures stress is a common psychometric 
instrument utilized in health research (Cohen, Kamarck, & Mermelstein, 1983). In a systematic 
review of psychometric instruments utilized to assess psychological stress in pregnant women, 
the PSS was found to be the most reliable instrument to measure the stress that may result from 
daily hassles (Nast, Bolten, Meinlschmidt, & Hellhammer, 2013). A more comprehensive 
discussion of the PSS instrument is included later in this review. The Perceived Stress Scale 
(PSS) measures the degree in which situations are regarded as unpredictable, uncontrollable and 
burdensome during the past days/weeks/month and it is adequate to measure disturbances by 
daily hassles. 
In summary, the cognitive perception of stress is processed through the central nervous 
systems (sympathetic and HPA axis) which in turn stimulates neurotransmitters such as 
epinephrine and cortisol that regulate immune cell functions. This psychoneuroimmunological 
pathway is primarily designed to protect the human body. However, prolonged stress stimulates 
the HPA axis and is manifested by an increase in neurotransmitters such as cortisol. Cortisol can 
negatively alter the cytokine balance which can increase vulnerability to inflammation and/or 
infections. The mothers’ immune status is designed to protect the fetus during pregnancy and 
breastmilk is designed to continue this protection post-delivery.  It is important to explore 
whether maternal stress indicators (physical, psychological and environmental) are related to 
changes in immune components of breastmilk to determine the full potential of the protective 
properties of breastmilk for infant health.  
Maternal Stressors 
Stressors for women during the post-delivery period are defined in the literature as 
physical, psychological, and environmental.  Physical stressors such as age, race, previous 
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pregnancies, mode of delivery, smoking, infection, diabetes and hypertension are all stressors 
that can impact both maternal and infant outcomes. Psychological stressors such as the daily 
hassles encountered adjusting to the new role of motherhood may influence maternal and infant 
immunity. Environmental stressors such as socioeconomic status, caregiver status (number of 
children cared for) and relationship status are all associated with decreased immunity. Using the 
current literature, each stress indicator will be further defined as it relates to mothers post-
delivery.  
Physical Stressors 
Age. The median age for women delivering term infants in the US has increased steadily 
from 25.8 years in 2011 to 25.6 years in 2012 (Carolan & Fankowska, 2011; National Vital 
Statistics Reports, 2013). As of 2012, 34.4% of all women delivering infants were 20-29 years of 
age (March of Dimes, 2012). In a large cohort of 215, 344 births, advanced maternal age ( >40) 
was associated with adverse birth outcomes such as increased risk of stillbirth (RR=1.83, [95% 
CI=1.37, 2.43]), preterm birth (RR=1.25, [95% CI= 1.14, 1.36]), delivery of large for gestational 
age infant (RR=1.40, [95% CI= 1.25, 1.58}), and caesarian delivery (RR=1.83, [95% CI= 1.77, 
1.90]) even after controlling for number of previous pregnancies, social deprivation, and 
ethnicity (Kenny et al., 2013). Comparing maternal age >35 to those aged 20-34, the odds 
increased for stillbirth (OR=1.5 [95% CI= 1.4, 1.7]), preterm birth (OR=1.2 [95% CI= 1.1, 1.2]), 
and early neonatal mortality (OR=1.2 [95% CI= 1.0, 1.4]) after controlling for facility and 
country in another large cohort of 308,149 women delivering among 9 countries (Laopaiboon et 
al., 2014). Advanced maternal age of > 30 years (49% of all US deliveries) is a significant 
maternal stressor and poses a risk of adverse maternal and infant outcomes (Carolan & 
Fankowska, 2011; Kenny et al., 2013; March of Dimes, 2012).    
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Race.  Race is associated with health disparities thus can be considered a maternal stress 
indicator.  In a systematic review, Beckie (2012) reported that race/ethnicity and socioeconomic 
status was associated with an increase in stress and health disparities.  Although much research 
has focused on the unequal access to healthcare as a key driver of health disparities, a growing 
body of evidence is now exploring the effects of stress as a contributor to population health 
disparities. Here in the US, the health disparities for African Americans (AA) are numerous. 
African Americans are more likely to have hypertension and diabetes than non-Hispanic Whites 
and Hispanics (Centers for Disease Control and Prevention, 2010). African American women 
have greater rates of obesity, hypertension, pre-eclampsia and pregnancy related death than non-
Hispanic White and Hispanic women (Centers for Disease Control and Prevention, 2012c; Office 
on Women's Health, 2013). African American infants have the highest incidence of mortality 
during the first year of life and AA mothers have one of the lowest breastfeeding initiation rates 
regardless of socioeconomic or educational background (Centers for Disease Control and 
Prevention, 2012a; Ludington-Hoe, McDonald, & Satyshur, 2002; March of Dimes, 2010; 
Spencer & Grassley, 2013). Mothers of AA infants are less likely to receive breastfeeding 
education from their health provider, and less likely to receive family and community support to 
initiate and sustain breastfeeding (Spencer & Grassly, 2013).  
Race was also reported as a significant predictor of poor infant outcomes controlling for 
hospital characteristics and physician practice preferences in a large cohort of 25 facilities 
(N=62,816) (Wilson, Gance-Cleveland & Locus, 2011). African American infants were more 
likely to be admitted to a neonatal intensive care unit and to have lower Apgar scores (a measure 
of infant physiological stability) at 1 and 5 minutes post birth.  African American children have 
greater rates of asthma and allergies than Non-Hispanic White and Hispanic children (Centers 
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for Disease Control and Prevention, 2013). Childhood obesity rates among AA children are 
greater than Non-Hispanic Whites, and childhood diabetes is highest among AA children 
compared to all races/ethnicities (Centers for Disease Control and Prevention, 2012b; National 
Diabetes Information Clearinghouse, 2011). Increasing the dose of breastmilk consumed by AA 
children holds potential to reduce these immune-mediated conditions.   
Number of Previous Pregnancies.  Increased number of pregnancies can be a stressor for 
mothers. Women experiencing numerous pregnancies (multiparous) had associations with higher 
physical, psychosocial and environmental risk factors compared to women delivering their first 
child (primiparous) in a large cohort of 3, 260 mothers (Lanier & Jonson-Reid, 2014). Lower 
socioeconomic status (58.4%), smoking during pregnancy (28.5%), partner violence (7.5%), and 
low birth weight infants (30.3%) contributed to a significantly higher cumulative risk stress score 
(p<0.005) for multiparous women (Mean=5± 2.2) versus primiparous women (Mean= 3.8±1.9). 
In another large cohort, physical stress and strain was greater for primiparous (n=556) than 
multiparous (n=736). Primiparous were more likely to experience perineal trauma (OR= 2.54 
[95% CI= 1.96, 3.29]), lack of sleep related to baby crying (OR =1.44 [95%CI= 1.01, 1.58]) in 
the first 8 weeks post-delivery compared with multiparous women (Thompson, Roberts, Currie, 
& Ellwood, 2002). Primiparous may undergo more physical stress than multiparous post-
delivery, but numerous pregnancies potentially increases caregiver burden which is discussed 
later in this review.   
Mode of Delivery. Mode of delivery (vaginal, vaginal assist, and cesarean section) places 
different physical strain on the mothers’ physical and psychological recovery post-delivery. In a 
prospective observational study, mothers receiving anesthesia had significantly lower cortisol 
levels at delivery than mothers delivering without anesthesia regardless of mode of delivery. 
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Those mothers receiving epidurals (n=21) or cesarean sections (n=29) had lower cortisol levels 
(epidural=5.53 ±2 ng/mL, p=0.040, cesarean section= 2.64±.96 ng/mL, p<0.050) versus those 
women experiencing vaginal delivery (n=30) or extraction assist vaginal delivery (n=23) 
(vaginal= 7.43±22.6 ng/mL, extraction= 6.83±2.93 ng/mL) without anesthesia (Vogl et al., 
2006). The authors propose that anesthesia used during delivery dampened the stress reactivity 
response but the sample size was small, thus more research is needed to generalize these 
findings. In contrast, Thomspon and colleagues (2002) reported more physical stress in women 
receiving cesarean sections. Those women receiving cesarean sections were more likely to be 
readmitted for maternal problems (OR= 2.46 [95% CI= 1.11, 5.43]) than those experiencing 
assisted vaginal birth (OR= 2.23 [95% CI= 0.88, 5.48], p=0.006) (Thompson et al., 2002).  In 
addition, those women receiving cesarean sections reported greater exhaustion (OR= 1.45 [95% 
CI= 1.07, 1.98]) and bowel problems (OR= 1.57 [95% CI=1.16, 2.11]) at 8 weeks post-delivery 
than women experiencing assisted vaginal delivery. Physical recovery from birth mode can take 
up to 6 months post-delivery which adds to the maternal perceived stress during this critical time 
period.  
Smoking. Smoking exposes both the mother and infant to toxic chemicals such as 
nicotine, tar, and carbon monoxide both during pregnancy and post-delivery (March of Dimes, 
2014). These toxic chemicals promote oxidation which releases free radicals that can harm 
maternal tissues as well as developing fetal tissues. Women of lower socio-economic status 
without healthcare access are at increased risk of smoking regardless of race/ethnicity (Mund, 
Louwen, Klingelheofer, & Gerber, 2013). In 2009, the estimated prevalence of smoking among 
women of reproductive years (18-44years) in the US was 18.7% (non-Hispanic white women= 
22%, non-Hispanic black women= 15.7%) (Centers for Disease Control and Prevention, 2014b). 
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Obstetric complications for women who smoke during pregnancy include: premature rupture of 
membranes, preterm delivery, chorioamniotis, placental abruption, and pregnancy induced 
hypertension (Mund et al., 2013). The risk of stillbirth increased 23 % for smoking pregnant 
women. Children of women who smoke during pregnancy were at increased risk of low birth 
weight, congenital cardiac defects and oro-facial anomalies, preterm birth and sudden infant 
death syndrome (Centers for Disease Prevention and Control, 2014; Mund et al., 2013). Smoking 
mothers (2,602 of 11, 958) were less likely to breastfeed exclusively at 2 weeks (OR= 2.08 [95% 
CI= 1.94, 2.21]) than non-smoking mothers (Letson, Rosenberg, & Wu, 2002). Finally, women 
who smoke (n=82) had higher cortisol levels than non smoking mothers (n=118) at 6 months 
post-delivery (M=17.5 ± 10.6 ng/mL vs M =8.3 ±8.3 ng/mL) (Granger et al., 2007). Smoking is a 
significant stressor for maternal and infant health; however not much is known on whether 
smoking is related to changes in immune properties of breastmilk.  
Infection. Historically, pregnancy was thought to increase the risk of infection 
(Sappenfield, Jamieson, & Kourtis, 2013). Pregnancy does alter the cytokine balance within the 
mother in part to prevent the maternal immune system from rejecting the fetus (Ruiz & Avant, 
2005). A systematic review was conducted to determine if pregnant women had an increased 
susceptibility to infection (Sappenfield, Jamieson, & Kourtis, 2013). The authors concluded that 
pregnancy was associated with an increased severity of infectious diseases, particularly viral 
diseases, and the degree of severity increased with advanced stages of pregnancy. Common 
infectious states for pregnant women include: pyelonephritis, chorioamnionitis, septic abortion, 
and pneumonia (Morgan & Roberts, 2013). Post-delivery complications include: endometritis 
after vaginal delivery (Median=5%, Range=0-24%), endometritis after non-elective cesarean 
section (Median=28.6%, Range= 3-61%), and pyelonephritis (3-4% of all readmissions). Women 
 20 
 
of lower socio-economic status are at highest risk of urinary tract infection (Morgan & Roberts, 
2013). Because urine and kidney infections are the most common cause of septic shock for 
obstetric patients, the American College of Obstetricians and Gynecologists recommends urine 
screening during prenatal visits and aggressive treatment of urinary tract infections both prenatal 
and post-delivery. Broad spectrum antibiotics are the gold standard which should illicit clinical 
improvement within 24-48 hours. Extended use of antibiotics can disturb the composition of the 
intestinal microbiome of both mother and infant (Murgas Torrazza & Neu, (2011). Here in the 
U.S., 29.7% of women reported receiving antibiotics during pregnancy (Centers for Disease 
Control and Prevention, 2014a).  Maternal infection is a significant maternal stressor; however, 
not much is known about the relationship of maternal infection and/or antibiotic usage and 
alterations of immune components in breastmilk.  
Hypertension. Hypertension is considered an immune mediated disease for the precursor 
is inflammation of the arteries which is associated with stress (Alevizos et al., 2014; Calgani & 
Elenkov, 2006). The overall prevalence of hypertension among women aged 18-44 years in 2009 
was 10.2%; AA women had the highest prevalence (19.2% [95% CI=17.5, 20.9]) versus non-
Hispanic whites (9.3% [95% CI= 8.9, 9.8]) and Hispanics (8.2% [95% CI= 7.3, 9.2]) (Centers for 
Disease Control and Prevention, 2014b). In the South, AA women with lower socioeconomic 
status had higher odds of cardiovascular disease including hypertension than white women with 
low socioeconomic status (OR= 3 [95% CI= 1.3, 6.9] versus OR= 1.67 [95% CI=0 .9, 3.1]) 
(Davis, Gebreab, Quarells, & Gibbons, 2014). Hypertensive pregnant women are at risk of life 
threatening co-morbidities (Bramham et al., 2014). Adverse pregnancy outcomes associated with 
hypertension include: pre-eclampsia (25.9% [95% CI= 21, 31.5]), cesarean section (41.4% [95% 
CI =35.5, 47.7]), low birth weight < 2500 grams (16.9% [95% CI= 13.1, 21.5]), and perinatal 
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death (4% [95% CI= 2.9, 5.4]) (Bramham et al., 2014). Hypertension is a physical stressor for 
the mother, and this stressor is also associated with delayed milk production (Hurst, 2007). Not 
known is whether stress-mediated diseases such as hypertension influence milk immune 
properties.  
Diabetes. Diabetes mellitus (Type 1) is considered immune mediated diseases. Perceived 
stress activates the nervous system neurotransmitters such as cortisol, which alters glucose 
metabolism and decreases sensitivity to insulin (Chida & Hamer, 2008).  In a meta-analysis of 
psychological stress and the incidence of diabetes, the authors reported that there were no strong 
correlations among psychological factors (stressful events, and poor social support) and 
incidence of type 1 or type 2 diabetes; however, poor glucose control was associated with 
stressful events and poor social support (Chida & Hamer, 2008). The overall incidence of 
diabetes (excluding gestational diabetes) among women aged 18-44years was 3% in 2009; AA 
women had a greater incidence (5.1% [95% CI= 4.2, 6.2]) than non-Hispanic whites (2.3% [95% 
CI =2.1, 2.6]) or Hispanics (3.6% [95% CI= 2.9, 4.5])  (Centers for Disease Control and 
Prevention, 2014b).  
Gestational diabetes is a condition of abnormal glucose metabolism during pregnancy 
and the incidence is estimated as high as 9.2% among all pregnant women (Centers for Disease 
Control and Prevention, 2014c). Gestational diabetes is associated with both maternal and infant 
adverse outcomes: macrosomia (RR= 1.81[95% CI=1.47,2.22, p<0.001]), large for gestational 
age (RR=1.53 [95% CI=1.39, 1.69], p<0.001), perinatal mortality (RR=1.55 [95% CI=0.88, 
2.73], p=0.130), preeclampsia (RR=1.69 [95% CI=1.31, 2.18], p<0.001) , and cesarean section 
(RR= 1.37 [95% CI =1.24,1.51], p<0.001) (Wendland et al., 2012). Although women with 
diabetes are less likely to initiate or sustain lactation, lactation hormones play a protective role in 
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reducing the risk of developing type 2 diabetes in women with gestational diabetes (Finkelstein, 
Keely, Feig, Tu, & Yasseen, 2013; Schwarz et al., 2010). Women diagnosed with diabetes pre-
pregnancy or during pregnancy are at risk of adverse outcomes, decreased lactation initiation and 
duration but little is known about the related immune properties of breastmilk among women 
with diabetes.  
In summary, maternal physical stressors described here play unique roles in maternal 
stress with the potential to influence maternal and infant immunity. Breastmilk is the bridge 
between intra-uterine and extra- uterine immune protection of the newborn infant. Further 
research is warranted to explore whether there are significant alterations in milk immune 
protection related to maternal physical stress.  
Psychological Stressors 
Perceived Stress. Self-perceived stress is associated with immune dysregulation and 
dysfunction (Glaser & Kiecolt-Glaser, 2005; Segerstrom & Miller, 2004). During pregnancy and 
post-delivery women experience psychological stressors related to becoming a mother, and the 
changes in relationships with partners, family, and friends (Jevitt et al.,  2012). Maternal prenatal 
self-perceived stress can impact the function of the infant immune system. Maternal cortisol and 
cytokines can cross the placenta to down-regulate or suppress the fetal immune system post-
delivery. In animal studies, maternal stress hormones were associated with an increased level of 
interleukin 10 (IL-10) in the pup’s serum (Curtin, 2009). Interleukin-10 suppresses pro-
inflammatory cytokines and thus could contribute to a suppression of the immune response to 
pathogens. Wright et al., (2009) examined cytokine changes in cord blood at birth associated 
with maternal prenatal stress among 557 low income women. Women reporting self-perceived 
stress had children with significantly increased cord blood interleukin-8 (IL-8), a pro-
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inflammatory chemokine, creating a heightened immune state. Maternal prenatal self-perceived 
stress was used to predict infant illness in a longitudinal study of 174 women who delivered term 
infants (Beijers,Jansen, Riksen-Walraven, & de Weerth, 2010). Prenatal self-perceived stress 
predicted the following infant illnesses: respiratory infections (9.3%), general illness (10.7%), 
skin infection (8.9%), and antibiotic use (7.6%) during the first year of infant life.   
Post-delivery, there are relationships between maternal self perceived stress and immune 
function reported in the literature.  Groer and colleagues, (2005), examined the relationships 
among maternal fatigue, infection and infection symptoms using the Carr Infection Symptom 
Checklist (SCL) in 50 women who delivered term infants. Greater maternal fatigue post-delivery 
correlated with higher maternal SCL scores (r = 0.22, p = 0.020), and greater maternal sleepiness 
correlated with more infections in both the mother (r = 0.29, p = 0.002) and infant (r = 0.28, p = 
0.002).   
The act of breastfeeding may suppress neuroendocrine responsiveness to physical and 
psychological stress. In a study exploring stress and immunity among women who formula fed 
versus women who breastfed, Groer and colleagues (2006) reported that total infection 
symptoms among women who formula fed their infants positively correlated with maternal self-
perceived stress on the day of the survey (r=0.26, p< 0.010) and the time since the birth of their 
infant 4-6 weeks ago (r =0.30, p< 0.001). The women who breastfed their infants did not 
demonstrate these correlations, nor were there significant correlations between maternal stress 
and serum cytokines.  
Perceived Stress and Cortisol. To date there is little research exploring the relationships 
among maternal self perceived stress, cortisol and milk immune composition post-delivery. In 
animal research, lactating rats were fed water laced with corticosterone. The infant pups had 
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greater levels of corticosterone in their serum and in the milk from their stomachs (Zahwa, Yorty 
&  Bonneau, 2008). The infant rats also demonstrated immune suppression (decreased 
interleukin-2) in response to a herpes simplex virus exposure.  
In human research,  Groer , Humenick & Hill (1994) found that increased maternal anger 
and vigor was significantly correlated with greater levels of milk secretory immunoglobulin A 
(SIgA) (Anger r=0.20, p<0.050, Vigor r=0.35, p< 0.050) in 29 mothers of preterm infants on day 
5 post-delivery; however, the correlations were small leaving 88%-96% of the observed 
variances unexplained. There was an inverse relationship between milk cortisol and the milk 
SIgA (r= -0.35, p= 0.050). The authors noted that the elevated milk cortisol could have been 
related to the manipulation of breast tissues via breastfeeding or pumping. The inter-relationships 
of these variables from the mothers of preterm infants are depicted in Figure 3 below which 
illustrates that the milk cortisol was not influenced by maternal anger and vigor.  
 
 
 
 
 
Figure 3. Direct Associations of Maternal Anger/Vigor with Milk SIgA 
Later, Groer, Davis and Steele (2004) explored the relationships among maternal self-
perceived stress, maternal serum cortisol, and milk immune composition among 50 mothers of 
term infants. The authors reported that mothers with higher self-perceived stress (PSS scores) 
had significantly higher serum cortisol values (r=0.25, p=0.040); and mothers with higher 
perceived stress had significant greater levels of milk SIgA (r=0.25, p=0.006) at 4-6 weeks post-
delivery. Greater levels of maternal serum cortisol were correlated with significantly greater 
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levels of milk SIgA (r =0.26, p=0.035). Using the diagram in Figure 4 below, we can see that 
there was a slightly stronger relationship of maternal serum cortisol with increased levels of milk 
SIgA than maternal stress with increased levels of milk SIgA. The serum cortisol may have 
mediated the direct associations of maternal stress (PSS summed scores) and milk immune 
components; however, the relatively low correlation leaves 93% of the variance in this 
relationship unexplained and may not be clinically meaningful. Further research is needed to 
explore whether these relationships are consistent among different populations of women.  
 
 
 
 
Figure 4: Direct and Indirect Associations of Maternal Perceived Stress with Milk SIgA and 
Maternal Cortisol with Milk SIgA 
 
Perceived Stress Scale. A psychometric instrument frequently used to measure self 
perceived stress in health research is the Perceived Stress Scale (PSS) (Cohen, Kamarck & 
Mermelstein,  1983). It is a 14 item instrument with a five point Likert type scale response 
format (0= never and 4= very often). The original instrument was tested in a community sample 
of college students (n=446) and a smoking cessation sample (n=64). The initial internal 
reliability for this scale ranged from α= 0.84-0.86. The test-retest reliability in the community 
sample was α= 0.85. Subsequent testing of the psychometric properties of the PSS using various 
languages and populations has shown consistent internal reliability (Leung, Lam, & Chan, 2010; 
Mimura & Griffiths, 2004; Ramirez, & Hernandez, 2007; Sharp, Kimmel, Kee, Saltoun, & 
Chang, 2007). During initial analyses of this scale, construct validity was demonstrated by 
significant correlations with the College Student Life Event Scale (r=0.76, p<0.001), and the 
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Cohen-Hoberman Inventory of Physical Symptoms (r=0.52, p<0.001) (Cohen, Kamarack, & 
Mermelstein, 1983). Subsequent analysis using the PSS in pregnant women reported internal 
reliability (α.= 0.84-0.86) and concurrent validity in women post-delivery with the Tennessee 
Post-Partum Stress Scale (r=0.62, p< 0.001), serum cortisol (r=0.25, p=0.040) and milk SIgA 
(r=0.25, p=.006) (Groer  et al., 2005; Groer , Davis, & Steele, 2004; Nast, Bolten, Meinlschmidt, 
& Hellhammer, 2013). The PSS summed scores among women post-delivery at 4-6 weeks 
(N=352) in several studies were higher (M ranges= 21.3-27.7) than other adult females (25-34 
years) in three large cohorts  from 1983 (N=593, M =13.45), 2006 (N=331, M =17.78), and 2009 
(N=433, M =17.46) (Cohen & Janicki-Deverts, 2012; Groer  et al., 2005; Groer , 2005; Groer , 
Davis, & Steele, 2004). No studies to date have correlated the PSS scores with salivary cortisol 
within the first two weeks post-delivery which is the time when a mother is adjusting to the new 
and stressful care-taker responsibilities of motherhood. 
In summary, psychological stress is associated with immune system changes conducted 
via the psycho-neuro-endocrine-immunological pathways. Neurotransmitters such as cortisol 
influence immune cell function but these relationships are also influenced by personal factors 
such as physical and environmental stress indicators. Earlier research describes a weak but 
significant relationship of maternal stress with serum cortisol, and serum cortisol with increased 
antibodies in milk. Further research is needed to explore the relationships of maternal stress and 
salivary cortisol with milk cytokines which are the messengers of the immune system capable of 
altering the direction of the immune response (pro-inflammatory/anti-inflammatory). 
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Environmental Stressors 
Environmental stressors such as lower socioeconomic status, caregiver role, and 
relationship status are associated with immunity changes across populations (Beckie, 2012; 
Cohen, Doyle, & Baum, 2006).   
Lower Socioeconomic Status. For women of childbearing ages, lower socioeconomic 
status is associated with poor access to health care, poor health behaviors, and adverse pregnancy 
outcomes (Marinda, Maxson, & Edwards, 2009; Ruiz & Avant, 2005). In a cohort of 294 low-
income women, the following conditions increased the odds of delivering a low birth weight 
infant: home crowdedness (OR=2.7 [95% CI=1.3-5.6]), job loss (OR=3.1 [95% CI=1.2-7.9]), 
insecurity over food resources (OR=3.2 [95% CI=1.4-7.2]) (Bryant Borders, Grobman, Amsden, 
& Holl, 2007). Racial disparities exist among those with lower socioeconomic status: low 
income AA women deliver more infants with low birth weight <2500 grams) than non-Hispanic 
whites and Hispanics (Miranda et al., 2009).  
Public assistance for health care, Medicaid, is often used as a definition of lower 
socioeconomic status. Medicaid enrollment has increased since the roll out of the Affordable 
Care Act. Adults enrolled in Medicaid are 70% more likely to have access to a regular place for 
health care (The Henry J. Kaiser Family Foundation, 2013). It is too early to determine whether 
the health behaviors of pregnant or lactating women supported by Medicaid have increased 
related to regular access to care providers; however, the status of Medicaid support indicates the 
stressor of low income therefore remains an important environmental maternal stressor. 
Caregiver Role. Caregiver stress is associated with an increased susceptibility to disease 
(Kiekolt-Glaser et al., 2003; Rice, 2000; Segerstrom & Miller, 2014). The majority of care-giver 
stress and immunity research has been conducted on elderly caregivers. Immune cell alterations 
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such as the  increased production of pro-inflammatory cytokines is associated with caregiver 
stress in those caring for the elderly (Lovell & Wetherell, 2011). Parents of medically fragile 
children report greater financial stress, relationship stress, fatigue, and susceptibility to illnesses 
than parents caring for healthy children (Kuster & Merkle, 2004). Mothers caring for more than 
one child report lower parenting satisfaction than mothers caring for one child (χ² =4.72, 
p=0.030); however breastfeeding and social support appears to buffer the effects of this stressor 
for all mothers (Hung, 2007; Lovell & Wetherell, 2011; Tu, Lupien, & Walker, 2006b). 
Caregivers of ill children had lower morning cortisol values and elevated pro-inflammatory 
immune cells thus it is logical that caregiver strain could be a maternal stressor for women caring 
for multiple children, at least during the first weeks post-delivery when the mother is also caring 
for a newborn (Jevitt et al., 2012; Lovell & Wetherell, 2011).   
Relationship Status. Supportive social networks (partner, family, and friends) can 
improve one’s ability to cope with a stressor (Beckie, 2012; Rice, 2005). Women reporting a lack 
of social support have greater odds of experiencing adverse outcomes such as the delivery of a 
low birth weight infant (OR=2 [95% CI=0.97, 4.1], p=0.060), and higher percentage of infant 
mortality (Centers for Disease Control and Prevention, 2013a). Relationship status can be a 
descriptive for social support. Single mothers are at greater risk of being below the federal 
poverty level, living in unstable environments, and dependent on public assistance (Child Trends 
Data Bank, 2014). In 2010, 39% of women aged 18-44 years old giving birth were either single, 
married and separated, or married with absent spouse (United States Census Bureau, 2013). In 
2013, 71% of all births to non-Hispanic Blacks and 53% to Hispanics occurred outside of 
marriage compared to 29% non-Hispanic white women; although, there is an increasing trend of 
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births to unmarried cohabitating couples across all races/ethnicities. Given this information, 
social support can be defined as married, with partner, or single.  
In conclusion, post-delivery maternal stress is associated with alterations in maternal and 
infant immunity. Increased levels of maternal serum cortisol can be transferred into milk and 
potentially suppress the infant immune response in animals. However, lactation may dampen the 
degree of the maternal stress response. There are no clear relationships between maternal stress 
indicators (physical, psychological, and environmental), maternal cortisol, and milk immune 
components. Further study is needed to determine the explained variance of the milk immune 
components in association with maternal stress indicators (physical, psychological, and 
environmental) and maternal cortisol.  
Milk Immune Properties and Maternal Characteristics 
Human milk is considered the immunological bridge for protecting the infant after 
delivery by providing both passive and active immune protection (Garofalo, 2010). The milk 
immune components consist of many cells such as immunoglobulins, growth factors, cytokines 
and chemokines. Each immune component plays a special role in providing protection and 
instruction for the developing infant immune system (Agarwal et al., 2011; Goldman, 2007; 
Lars, 2004).  
 Colostrum is the first milk produced 0-3 days post-delivery and contains larger amounts 
of immune components than mature milk (Agarwal et al., 2011; Goldman, 2007; Lars, 2004). 
After 5-9 days mature milk is established and contains increasing levels of fats and 
carbohydrates necessary for infant growth along with decreasing levels of immune components, 
primarily the pro-inflammatory cytokines. However, the volume of milk consumed by the infant 
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increases over time, thus it is postulated that the immune component levels consumed by the 
infant stabilize over time affording long-term on-going protective benefits to the infant.  
 The immune components selected for this study provide the infant with optimum 
immune protection. These include: secretory Immunoglobulin A (SIgA), epidermal growth factor 
(EGF), Interleukin-4 (IL-4), Interleukin-6 (IL-6), Interleukin-8 (IL-8 or CXCL8), Interleukin-10 
(IL-10), Tumor necrosis factor-alpha (TNF-α), Interferon gamma-induced protein 10 (IP-10 or 
CXCL10), Monocyte chemotactic protein 1(MCP-1 or CCL2), and Macrophage inflammatory 
protein (MIP-1α or CCL3). See below for a summary of the milk immune component ranges 
during the first 14 days post-delivery among mothers of term infants. 
Table1: Summary of Milk Immune Component Ranges Day1- 14 Post-Delivery  
Note: References- Amoudruz et al., 2008; Araújo et al., 2005; Böttcher et al, 2008; Castellote et al., 2011, 
Ciardelli et al., 2007; Erbağci et al., 2005; Ermis et al., 2009; Fituch et al., 2004;  Groer  et al., 1994; 
Holmlund et al., 2010; Kverka et al., 2007; Marek et al., 2009;  Mehta & Petrova et al., 2011; Meki et al., 
2003; Montagne et al., 1999; Ogawa et al., 2004; Prokešová  et al., 2006; Rigotti et al., 2006; Takahata et 
al., 2003; Tregoat et al., 2001; Yilmaz et al., 2007; Zannardo et al., 2007.  
 
Secretory Immunoglobulin A 
 
Secretory Immunoglobulin A (SIgA) is the predominant antibody in milk and is essential 
for the immune protection of the infant mucosa which is the location where pathogens cross-over 
into the blood stream and accounts for over 90% of infant infections (Agarwall et al., 2011; 
Brandtzaeg, 2003, 2010; Lawrence & Pane, 2007). Secretory IgA is very resistant to a harsh 
Immune 
Component 
Cross-sectional Longitudinal Number of 
Participants 
Range 
Day 1-14 Post-delivery 
SIgA 5 3 576 0.35-117 mg/mL 
EGF 1 1 39 0-130.4 pg/mL 
IL-4 2 1 78 0.33-2150 pg/mL 
IL-6 6 6 562 0-1097 pg/mL 
IL-8 5 4 448 1.6- 16081 pg/mL 
IL-10 7 6 713 0-327 pg/mL 
TNF α 4 6 512 0-432.5 pg/mL 
IP10 1 1 106 0-2861.4 pg/mL 
MCP-1 1 0 13 0- 7.09 pg/mL 
MIP-1α 0 0 0 NA 
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environment such as the stomach and arrives intact in the infant intestines where infant immunity 
instruction begins. 
 Eight studies have reported SIgA levels ranging between 0.35-117 mg/mL in colostrums  
and mature milk up to 14 days post-delivery among mothers of term infants (N=576); the range 
in values increases to 0.35-275 mg/mL up to 11 months post-delivery (Araújo et al., 2005; 
Böttcher et al., 2008; Castellote et al., 2011; Ciardelli et al., 2007; Cruz et al., 1982; Ermis, 
Yildrim, Tastekin  & Ors, 2009; Groer  et al., 2005; Groer  & Shelton, 2009; Groer  et al., 2004; 
Groer  et al., 1994; Montagne, Cuillière, Molé, Béné & Faure, 1999; O’Connor, Schmidt, 
Carroll-Pankhurst  & Olness, 1998; Sakamoto et al., 2007; Trègoat, Montagne, Bènè & Faure,  
2001).  
At 3 days post-delivery, Asian mothers of term infants had significantly greater levels of 
SIgA than African, Eastern European or Italian mothers (Ciardelli et al., 2007). Within 5 days 
post-delivery, breastfeeding satisfaction was statistically significantly associated with decreased 
levels of SIgA among 29 mothers of term infants (Groer et al., 1994). At 4-6 weeks post-
delivery, infection, serum cortisol, self-perceived stress were significantly associated with 
increased levels of milk SIgA  (N= 50) ( Groer  et al., 2004). All of these characteristics are 
considered maternal stressors.  No changes in milk SIgA levels were detected with exercise 
(N=58), relaxation sessions (N=38), or supplementation with probiotics during pregnancy (N=54) 
up to 11 months post-delivery (Böttcher et al., 2008; Groer & Shelton, 2009; O’Connor et al., 
1998). Lastly, a significant decrease in milk SIgA levels was associated with increased maternal 
age, smoking status, and higher income (N=50) (Groer et al., 2004). Overall, milk SIgA 
decreases steadily from 0-14 days post-delivery across all longitudinal studies (Böttcher et al., 
2008; Castellote et al., 2011; Montagne et al., 1999). To date, maternal physical, psychological 
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and environmental stressors were associated with changes in the levels of milk SIgA (see Table 
2); however, within 14 days post-delivery not much is known about these relationships.  
Table 2: Summary of Maternal Characteristics and Milk SIgA  
Time Condition Study N Milk Values 
Median 
(Range) 
Test p-value 
3 days pp Maternal history of 
allergy disease-prenatal 
probiotics 
Böttcher et al., 
2008 
54 2.2 
(1.4-2.7) 
 > 0.050 
3 days pp  Maternal history of 
allergy disease-placebo 
Böttcher et al., 
2008 
55 2.2 
(1.5-3.5) 
  
3 days pp Italy Ciardelli et al., 
2007 
40 4.5 
(1.9-8.3) 
  
3 days pp Africa Ciardelli et al., 
2007 
24 11.7 
(5.2-27.8) 
  
3 days pp Asia Ciardelli et al., 
2007 
24 13.2 
( 1.4-42) 
 0.007 
3 days pp Eastern Europe Ciardelli et al., 
2007 
24 8.1 
(3.1-36) 
  
5 days pp Breastfeeding satisfaction  Groer  et al., 
1994 
29 209 r= -0.51 0.006 
1 mon pp Maternal history of 
allergy disease-prenatal 
probiotics 
Böttcher et al., 
2008 
54 2.2 
(1.4-2.7) 
 > 0.050 
1 mon pp  Maternal history of 
allergy disease-placebo 
Böttcher et al., 
2008 
55 2.2 
(1.5-4.3) 
  
    Mean±SD   
4-6 wks pp Relaxation intervention O’Connor et 
al., 1998 
14 0.47±0.29  > 0.050 
4-6 wks pp No relaxation intervention O’Connor et 
al., 1998 
9 0.49±0.42   
4-6 wks pp Age  Groer  et al., 
2004 
50 497±3.17 r= -0.32 0.010 
4-6 wks pp Smoking  Groer  et al., 
2004 
9 1106   0.008 
4-6 wks pp Infection  Groer  et al., 
2004 
50 497±3.17 r=0.37 0.010 
4-6 wks pp Serum Cortisol   Groer  et al., 
2004 
50 497±3.17 r=0.26 0.035 
4-6 wks pp Perceived Stress (PSS)  Groer  et al., 
2004 
50 497±3.17 r=0.25 0.006 
4-6 wks pp Income  Groer  et al., 
2004 
50 497±3.17 r= -0.34 0.008 
4-6 wks pp Exercise  Groer  et al., 
2009 
58 2.96± 0.29 r=0.12  <0.390 
Note= Values reported mg/mL; pp= post-delivery 
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Epidermal Growth Factor 
Epidermal growth factor (EGF) is one of several growth factors present in human milk. 
Epidermal growth factor is considered an anti-inflammatory immune component that promotes 
intestinal epithelial cell growth and maturation thus it is a major contributor to infant intestinal 
wall integrity (Lars, 2004). However, EGF may also have some immune modulating effects on 
infant intestinal cells by increasing absorption and permeability.  
In two human milk studies enrolling mothers of term infants (N=69) the reported EGF 
levels ranged from 0-130.4 pg/mL from 0-14 days post-delivery; one study at 3-4 weeks post-
delivery (N=30) found an increased range of EGF 35.3-283.2 pg/mL (Castellote et al., 2011; 
Kumral et al., 2009; Kverka et al., 2007). The EGF levels in colostrums were greater than mature 
milk during the 0-14 day post-delivery window. Infants with jaundice consumed milk with 
increased levels of EGF in the 3
rd
-4
th
 week post-delivery compared to infants without jaundice 
(N=30) (Kumral et al., 2009) (see Table 3). In this study there were no significant differences in 
maternal demographic variables that may contribute to the variance in EGF; however, EGF could 
potentially increase infant intestinal absorption of bilirubin. More research is needed to clarify 
this relationship. In the one longitudinal study, the levels of EGF steadily declined over days 0-
14 post-delivery (Castelotte et al., 2011) see Table 3.  
Table 3: Summary of Maternal/Infant Characteristics and Milk EGF 
Time Condition Study N Milk Values 
Mean±SD 
p-value 
3±1 day pp Term Castelotte et 
al., 2011 
22 75.6±54.8  
10± day pp  Term Castelotte et 
al., 2011 
22 29.4±9.5 0.050 
21-28 day pp Milk Consumed by Infants with 
Neonatal Jaundice Jaundice 
Kumral et 
al., 2009 
15 232.2±51 0.020 
21-28 day pp Milk Consumed by Infants with 
No Neonatal Jaundice 
Kumral et 
al., 2009 
15 129±35.5  
Note: Values reported as pg/mL; pp= post-delivery. 
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Interleukin-4 
Interleukin-4 (IL-4) is a cytokine in milk with a reported range of 0.33- 2,150 pg/mL in 
three studies enrolling 78 mothers of term infants from 0-14 days post-delivery; two additional 
studies reported ranges of 25-1031 pg/mL among 110 mothers up to 6 months post-delivery 
(Groer  & Beckstead, 2011; Groer  & Shelton, 2009; Kverka et al., 2007; Marek et al., 2009; 
Prokešová et al., 2006). Interleukin-4 influences changes in naïve T cell lymphocytes which 
stimulate increased production of more IL-4 components. Marek and colleagues (2009) reported 
decreased IL-4 levels in colostrums 2-3 days post-delivery from 30 mothers with allergic disease 
versus 46 mothers without allergic disease, although not statistically significant. In contrast, 
Prokešová and colleagues (2006) reported significantly greater levels of  IL-4 at 3 and 6 months 
post-delivery in mothers with allergic disease delivering term infants (n=39) versus healthy 
mothers (n=37) but there were no differences in colostrum IL-4 levels (see Table 4). To date, 
there is not sufficient evidence to associate milk IL-4 levels with allergic symptoms in infants. 
The levels of IL-4 varied over time between mothers with or without allergies. Those mothers 
with allergies had increased levels of IL-4 over 0-3 months days post-delivery (Prokešová et al., 
2006).  
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Table 4: Summary of Maternal Characteristics and Milk IL-4 
Time Condition Study N Milk Values 
Mean±SD 
p-value 
 2-3 days pp Allergy Marek et al., 2009 30 0.33±0.34 <0.053 
 2-3 days pp No Allergy Marek et al., 2009 46 0.36 ±0.37  
    Median 
(Range) 
 
4 days pp Allergy Prokešová  et al.,2006 20 235 
(134-2150) 
0.118 
 4 days pp No Allergy Prokešová  et al.,2006 21 172 
(53-261) 
 
 3 mon pp Allergy Prokešová  et al.,2006 14 362 
(92-1031) 
0.009 
 3 mon pp No Allergy Prokešová  et al.,2006 18 83 
(13-180) 
 
 6 mon pp Allergy Prokešová  et al.,2006 11 248 
(84-363) 
0.032 
 6 mon pp No Allergy Prokešová  et al.,2006 16 61 
(25-114) 
 
Note: Values reported as pg/mL; pp=post-delivery 
Interleukin-6 
Interleukin-6 (IL-6) is cytokine in milk possessing both pro-inflammatory and anti-
inflammatory actions (Agarwal et al., 2011). IL-6 crosses the blood brain barrier and is 
responsible for the symptoms of feeling ill and generating fever (Janeway et al., 2005).  
Although the main actions of IL-6 are to produce an inflammatory response to tissue injury, IL-6 
can modulate other immune components to increase the production of SIgA and IL-10 (Agarwal 
et al., 2009). In 12 studies exploring the levels of IL-6 in mothers of term infants (N=562), the 
reported range was 0-1097 pg/mL from 0-14 days post-delivery; extending to 6 months post-
delivery, the reported range of IL-6 was 1.1-8603 pg/mL (N=152) (Amoudruz et al., 2009; 
Apaydin et al., 2012; Castellote et al., 2011; Ciardelli et al., 2007; Erbağci et al., 2005; Groer  & 
Beckstead,  2011; Groer  & Shelton, 2009; Hawkes, Bryan, Makrides, Neumann & Gibson, 
2002; Holmlund et al., 2010; Kverka et al., 2007; Mehta & Petrova, 2011; Meki, Saleem, Al-
Ghazali, Sayed, 2003; Ogawa et al., 2004; Prokešová et al., 2006; Zanardo et al., 2007).  
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Among maternal characteristics, increased levels of milk IL-6 were associated with 
ethnicity at 5 days post-delivery; Asian mothers (n=24) had significantly increased levels of IL-6 
compared with African (n=24), Italian (n=40) Eastern European mothers (n=24) (Ciardelli et al., 
2007). Also at 3-5 days post-delivery, immigrants (n=32) had significantly greater levels of IL-6 
than the local population (n=32) (Amoudruz et al., 2008); and mothers delivered by caesarian 
section delivery had greater levels of IL-6 (n=10) ( Mehta & Petrova et al., 2011). However, no 
changes in milk IL-6 were noted in another study comparing milk from immigrant (n=32) versus 
local populations (n=33) on day 5 (Holmlund et al., 2011). Maternal prenatal consumption of 
omega-3 fatty acid supplements (n=29) was associated with decreased levels of milk IL-4 versus 
placebo (n=25) at 4 weeks post-delivery (Hawkes et al., 2002) (see Table 5).  The studies 
exploring the association of IL-6 with immigrant versus local populations were conducted in 
Sweden; the locals (Swedish mothers) were compared with women born in underdeveloped 
countries who then moved to Sweden. Amoudruz and colleagues (2008) suggest that the prior 
exposure to pathogens in under-developed countries might be the reason for the increased levels 
of IL-6 in the milk from the immigrant women but this was not supported in the study conducted 
by Holmlund and colleagues (2011). Further research is needed to explore this relationship. 
 Interleukin-6 levels varied among milk consumed by infants with jaundice: one study 
reported infants with jaundice received significantly increased levels of milk IL-6 (n=32, 
p=0.010) versus those infants not jaundiced (n=29); whereas another study reported no 
differences in milk consumed by jaundiced infants (n=40) versus not jaundiced infants (n=40) 
(Apaydin et al., 2012; Zanardo et al., 2007). Small sample sizes and conflicting methods across 
studies indicate further research is needed to assess the variations of this component in milk 
associated with maternal/infant characteristics. The levels of IL-6 decreased over days 0-30 days 
 37 
 
post-delivery in three longitudinal studies (Castelotte et al., 2011; Erbağci et al., 2005;  Mehta & 
Petrova et al., 201l).   
Table 5: Summary of Maternal/Infant Characteristics and Milk IL-6 
Time Condition Study N Milk Values 
Median 
(Range) 
p-value 
3 days pp Milk Consumed by 
Infants with Neonatal 
Jaundice Jaundice 
Zanardo et al., 
2007 
32 17.5 
(11.6-32.3) 
0.100 
3 days pp Milk Consumed by 
Infants with No 
Neonatal Jaundice 
Zanardo et al., 
2007 
29 15.5 
(6-40.8) 
 
3 days pp Italy Ciardelli et al., 
2007 
40 8.3 
(4.5-25.1) 
 
3 days pp Africa Ciardelli et al., 
2007 
24 4.35 
(1.8-25.7) 
 
3 days pp Asia Ciardelli et al., 
2007 
24 7 
(3.6- 41.8) 
0.004 
3 days pp Eastern Europe Ciardelli et al., 
2007 
24 9.6 
(1.8- 48.1) 
 
3-5 days pp Immigrant Amoudruz et 
al., 2008 
32 58.8 
(7-411) 
0.035 
3-5 days pp Local Amoudruz et 
al., 2008 
32 38 
(5.4-1097) 
 
 3-5 days pp Immigrant Holmlund et al., 
2010 
32 44 
(7-411) 
> 0.050 
3-5 days pp Local Holmlund et al., 
2010 
33 29 
(5.4-1097) 
 
12-24 days pp Milk Consumed by 
Infants with Neonatal 
jaundice 
Apaydin, 2012 20 3 
(1.4-11.4) 
0.174 
12-24 days pp Milk Consumed by 
Infants with No 
Jaundice  
Apaydin, 2012 20 7.2 
(1.4-14.6) 
 
20-29 days pp Cesarean section   Mehta & 
Petrova et al., 
2011 
10 32.6 ±8.1 <0.050 
4 wks pp 600 mg DHA Hawkes et al., 
2002 
29 845 
(53-2598) 
<.0.050 
4 wks pp Placebo Hawkes et al., 
2002 
25 882 
(50-2028) 
 
Note: Values reported as pg/mL; pp=post-delivery 
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Interleukin-8 
Interleukin-8 (IL-8) is a pro-inflammatory chemokine that recruits white blood cells to 
tissues that are inflamed by infection or trauma, thus IL-8 plays a contributing role in signaling 
the inflammatory response (Agarwal et al., 2011). Among nine studies enrolling 448 mothers of 
term infants the reported range of IL-8 in milk was 0-16 801 pg/mL from 0-14 days post-
delivery; the range did not change in additional studies (N=78) exploring milk from 0- 6 months 
post-delivery (Amoudruz et al., 2008; Apaydin et al., 2012; Castellote et al., 2011; Ciardelli et 
al., 2007;  Erbağci et al., 2005;  Groer  & Shelton, 2009;  Groer  & Beckstead, 2011; Holmlund 
et al., 2010; Kverka et al., 2007;  Mehta & Petrova & Petrova, 2011; Meki et al., 2003, Zanardo 
et al., 2007).  
Women 5 days post-delivery from Eastern Europe (n=24), and immigrants from 
underdeveloped countries living in Sweden had greater levels of IL-8 (n=64) versus locals 
(n=65) (Amoudruz et al., 2008; Ciardelli et al., 2007; Holmlund et al., 2010) (see Table 6). As 
seen with IL-6, there were conflicting IL-8 values reported in milk consumed by infants with 
jaundice and those without jaundice (Apaydin et al., 2012; Zanardo et al., 2007). Clearly the 
reported changes in milk consumed by infants with jaundice are not consistent and the variances 
described are most likely related to the small sample sizes and differences in collections. 
Associations are limited at this time. The levels of IL-8 decreased over days 0-30 post-delivery 
in four longitudinal studies (Castellotte et al., 2011; Erbağci et al., 2005; Mehta & Petrova et al., 
2011; Meki et al., 2003).   
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Table 6: Summary of Maternal/Infant Characteristics and Milk IL-8 
Time Condition Study N Milk Values 
Median 
(Range) 
p-value 
3 days pp Milk Consumed by Infants 
with Neonatal Jaundice 
Jaundice 
Zanardo et al., 
2007 
32 752 
(465-3496) 
0.090 
3 days pp Milk Consumed by Infants 
with No Neonatal Jaundice 
Zanardo et al., 
2007 
29 583 
(247-7052) 
 
3 days pp Italy Ciardelli et al., 
2007 
40 2532 
(931-8077) 
 
3 days pp Africa Ciardelli et al., 
2007 
24 2223 
(1534-6298) 
 
3 days pp Asia Ciardelli et al., 
2007 
24 4676 
(1483-15978) 
 
3 days pp Eastern Europe Ciardelli et al., 
2007 
24 10477 
(2081-16081) 
0.026 
3-5 days pp Immigrant Amoudruz et 
al., 2008 
32 565 
(83-3219) 
0.017 
3-5 days pp Local Amoudruz et 
al., 2008 
32 191 
(57-6955) 
 
 3-5 days pp Immigrant Holmlund et 
al., 2010 
32 520 
(61-3219) 
0.043 
3-5 days pp Local Holmlund et 
al., 2010 
33 305 
(57-6955) 
 
12-24 days pp Milk Consumed by Infants 
with Neonatal jaundice 
Apaydin, 2012 20 247 
(101-439) 
0.285 
12-24 days pp Milk Consumed by Infants 
with No Jaundice  
Apaydin, 2012 20 166 
(75-478) 
 
Note: Values reported as pg/mL; pp=post-delivery. 
Interleukin-10 
Interleukin-10 (IL-10) is a primary moderator of the anti-inflammatory immune response 
by suppressing the Th1 cytokine response and increasing the natural killer cells (NK) that can 
destroy pathogens. This immune component is needed to prevent the self-destruction of host 
tissues once a pro-inflammatory response has been initiated (Agarwal et al., 2012; Garofalo, 
2010). In 13 studies of milk from mothers of term infants (N=713), the reported levels of IL-10 
range 0-327 pg/mL from 0-14 days post-delivery; the range increases to 0-562.2 pg/mL 
extending to 6 months post-delivery in four mores studies (Apaydin et al., 2012; Böttcher et al., 
2008; Castelotte et al., 2011; Ciardelli et al., 2007; Fituch, Palkowetz, Goldman, & Schanler, 
 40 
 
2004; Groer  & Beckstead, 2011; Groer  & Shelton, 2009; Holmlund et al., 2010; Kverka et al., 
2007; Marek et al., 2009; Mehta & Patrova, 2011; Meki et al., 2003; Ogawa et al., 2004; 
Prokešová et al.,  2006; Rigotti et al., 2006; Yilmaz, Saygili-Yilmaz, & Gunesacar, 2007; 
Zanardo et al., 2007).  
Overall, IL-10 levels were decreased in mature milk compared to colostrums. 
Significantly increased levels of IL-10 were reported in the colostrums (3 days post-delivery) in 
mothers supplemented with probiotics (n=54) versus placebo (n=55) and significantly greater 
levels were detected in mothers with allergic disease (n=21) versus mothers without allergic 
disease at 3 and 6 months post-delivery (Böttcher et al., 2008; Prokešová et al.,  2006) (see Table 
7). Women born in Africa (n=20) had significantly lower levels of IL-10 than those born in Asia 
(n=24) , Eastern Europe (n=24) , or Italy (n=40) (see Table 7) (Ciardelli et al., 2007). At 7 days 
post-delivery, there were no significant differences in the levels of  milk IL-10 from mothers of 
preterm and term infants; however within this cohort, preterm infants diagnosed with necrotizing 
enterocolitis consumed milk with undetectable or decreased levels of IL-10. This is logical for 
IL-10 is needed to prevent the infant host tissue destruction during an extreme inflammatory 
process such as necrotizing enterocolitis (Fituch et al., 2004). It is also suggested that IL-10 
assists with the tolerance of friendly bacteria in the intestines which are needed for digestion, 
thus this cytokine is important to infant intestinal  tissue health but the natural variations found in 
milk are still being discovered (Field, 2005). The levels of IL-10 both increased and decreased 
across time among four longitudinal studies (Böttcher et al., 2008; Kverka et al., 2007; Rigotti et 
al., 2006; Yilmaz et al., 2007).  
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Table 7: Summary of Maternal Characteristics and Milk IL-10 
Note: Values reported in pg/mL; pp= post-delivery 
Tumor Necrosis Factor-Alpha 
Tumor necrosis factor-alpha (TNF-α) is one of the most abundant milk immune 
components with pro-inflammatory actions and appears to regulate the immune components 
functions within milk (Argawal et al., 2010; Garofalo, 2010). The reported range of TNF-α in 
milk was 1-432.5 pg/mL among mothers of term infants (N=512) in 10 studies measuring milk 
0-14 days post-delivery; the range increased to 1-5607 pg/mL in four additional studies 
extending out to 6 months post-delivery (N=156) (Amoudruz et al., 2008; Apaydin et al., 2012; 
Time Condition Study N Milk Values 
Median 
(range) 
p-value 
3 days pp Maternal history of allergy 
disease-prenatal probiotics 
Böttcher et al., 2008 54 6.6 
(4.5-19) 
0.046 
3 days pp Maternal history of allergy 
disease-placebo 
Böttcher et al., 2008 55 4.8 
(1.2-12.7) 
 
3 days pp Italy Ciardelli et al., 2007 40 6.81 
(0.29-106) 
 
3 days pp Africa Ciardelli et al., 2007 24 0.42 
(0.17-4.3) 
0.045 
3 days pp Asia Ciardelli et al., 2007 24 3.86 
(0.25-85.7) 
 
3 days pp Eastern Europe Ciardelli et al., 2007 24 3.31 
(0.37-28.2) 
 
4 days pp Allergy Prokešová  et al.,2006 20 197  
 (46-327) 
0.072 
 4 days pp No Allergy Prokešová  et al.,2006 21 27   
(16-247) 
 
 7 days pp Preterm Fituch et al., 2004 15 30 
(0-283) 
0.630 
 7 days pp Term Fituch et al., 2004 16 43 
(31-227) 
 
 3 mon pp Allergy Prokešová  et al.,2006 14 400 
(205-524) 
0.005 
 3 mon pp No Allergy Prokešová  et al.,2006 18 75 
(18-335) 
 
 6 mon pp Allergy Prokešová  et al.,2006 11 27 
(13-280) 
0.022 
 6 mon pp No Allergy Prokešová  et al.,2006 16 246 
(148-525) 
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Böttcher et al., 2008; Castelotte et al., 2011; Erbağci et al., 2005; Ermis et al., 2009;  Groer  & 
Beckstead, 2011;  Groer  & Shelton, 2009; Hawkes et al., 2002; Holmlund et al, 2010; Kverka et 
al., 2007;  Mehta & Petrova & Patrova, 2011; Meki et al., 2003; Zanardo et al., 2007).  
Not many maternal characteristics (maternal allergy, immigrant status, consumption of 
omega 3 fatty acids supplements, and milk consumed by infants with jaundice) are linked with 
significant changes in the levels of TNF-α except for the significantly increased levels of TNF-α 
found in mothers of preterm infants 6-15 and 20-29 days post-delivery (n=40) and decreased 
levels of milk TNF-α among mothers who smoke (n=21) versus non-smokers (n=23) (Amoudruz 
et al., 2008; Böttcher et al., 2008; Ermis et al, 2009; Holmlund et al., 2010;  Mehta & Petrova & 
Patrova, 2011; Zanardo et al., 2007) (see Table 8). After controlling for gestational age on the 
Mehta and Petrova study (2011), those mothers delivered by caesarian section (n=40) had 
significantly greater levels of milk TNF-α  which makes sense for a pro-inflammatory response 
would be the first immune response from tissue injury such as surgery. Milk TNF-α protects the 
infant intestinal cells by regulating a pro-inflammatory immune response to pathogens (Field, 
2005; Garofalo, 2010). The levels of TNF-α decreased over 0-30 days post-delivery in five 
longitudinal studies (Böttcher et al., 2008; Erbağci et al., 2005; Meki et al, 2003; Mehta & 
Petrova, 2011).  
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Table 8: Summary of Maternal Characteristics and Milk TNF-α 
Time Condition Study N Milk Values 
Median 
(Range) 
p-value 
 3 days pp Term- maternal history of 
allergy disease-prenatal 
probiotics 
Böttcher et al., 2008 54 11 
(3.9-21) 
 
3 days pp Term- maternal history of 
allergy disease-placebo 
Böttcher et al., 2008 55 10 
(3.9-23) 
 
3 days pp Term with neonatal 
jaundice 
Zanardo et al., 2007 32 28.6 
(19.5-46) 
0.450 
3 days pp Term Zanardo et al., 2007 29 21.9 
(18.6-37.5) 
 
3-5 days pp Immigrant Amoudruz et al., 2008 32 4.4 
(1.8-69) 
0.749 
3-5 days pp Local Amoudruz et al., 2008 32 4.3 
(2.7-69) 
 
3-5 days pp Immigrant Holmlund et al., 2010 32 4.5 
(1.8-34) 
 
3-5 days pp Local  
 
Holmlund et al., 2010 33 4.3 
(2.6-69) 
 
6-15 days pp Preterm  Mehta & Petrova et al., 
2011 
30 32.3 
(11-69) 
<0.040 
6-15 days pp Term  Mehta & Petrova et al., 
2011 
10 17.2 
(13-25) 
 
7 days pp Smoking Ermis et al., 2009 21 Mean (SD) 
65.5(32) 
0.002 
7 days pp Non-Smoking Ermis et al., 2009 23 Mean (SD) 
158(117) 
 
20-29 days pp Preterm  Mehta & Petrova et al., 
2011 
30 25.2 
(10-58) 
 
<0.020 
20-29 days pp Term  Mehta & Petrova et al., 
2011 
10 15.3 
(10-26) 
 
Note: Values reported as pg/mL; pp = post-delivery. 
Interferon Gamma-Induced Protein-10, Monocyte Chemotactic Protein-1, and 
Macrophage Inflammatory Protein-1α 
 The next three immune components are chemokines which are small proteins grouped by 
two functions: facilitation of immune cell traffic near the site of an infection, and pro-
inflammatory immune response by stimulation of the attraction of immune cells to a particular 
bacteria or virus (Garofalo, 2010; Janeway 2005).  Interferon gamma-induced protein 10 (IP-10 
or CXCL 10), monocyte chemotactic protein-1 (MCP-1 or CCL2), and macrophage 
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inflammatory protein-α (MIP-1α or CCL3) have been detected in milk but there is little data on 
the ranges of these cytokines to date. Current ranges in the literature in milk from mothers 
delivering term infants 0-4 days post-delivery include IP-10 (0-2861 pg/mL, N=141); and MCP-
1 (0-6.1 pg/mL, N=13); two other studies measuring milk from term mothers at 4-6 weeks post-
delivery report ranges of IP-10 (0-2861 pg/mL, N=141); and MCP-1 (0-6.1 pg/mL, N=13 )and 
MIP-α ranged 14.1-41.5 pg/mL from 0-4 days post-delivery (N=78) (Groer  & Beckstead, 2011; 
Groer  & Shelton2009; Kverka et al., 2007; Takahata et al., 2003).   
These chemokines are important for they contribute to the protection of the infant against 
the transmission of viruses such as human immunodeficiency virus in breastmilk (Garofalo, 
2010). There was statistically significant decreases in IP-10 levels between colostrum (Day 0-3 
post-delivery) and mature milk (> 4 weeks post-delivery) among 72 mothers of term and preterm 
infants 0-> 4wks post-delivery (Takahata et al., 2003) (see Table 9).  
Table 9: Summary of Maternal Characteristics and Milk IP-10 
Time Condition Study N Milk Values 
Median 
(Range) 
p-value 
 0-3 days pp Term and preterm Takahata et al., 2003 39 1144.2   
(176-2861) 
<0.001 
 4-7 days pp Term and preterm Takahata et al., 2003 39 873.4 
(0-2457) 
 
>4 wks pp Term and preterm Takahata et al., 2003 32 518 
(81-1162) 
 
4-6 wks pp Term  Groer  et al., 2009 58 1618.3  
(2219.3) 
 
Note: Values reported as pg/mL; pp=post-delivery.  
There were no statistically significant associations with maternal characteristics and milk 
chemokines MCP-1 and MIP-1α in the literature to date (see Table 10).  
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Table 10: Summary of Milk MCP-1 and MIP-1α Values in the Literature 
Time Condition Study N Milk Values 
Mean±SD 
MCP-1     
0-3 day pp Term Kverka et al., 2007 13 6.1±0.99 
4-6 wks pp Term  Groer  et al., 2009 58 1,653.7±2,644 
4-6 wks pp Term  Groer  et al., 2011 20 682.7±2658 
MIP-1α     
4-6 wks pp Term  Groer  et al., 2009 58 14.1±41.5 
4-6 wks pp Term  Groer  et al., 2011 20 14.1±41.4 
Note: Values reported as pg/mL; pp= post-delivery. 
In summary, many of the milk immune components originate from the mammary gland 
tissues and immune cells; thus the reported levels in milk vary greatly.  The milk immune 
components function individually and synergistically to facilitate the development of an 
appropriate immune response within the immature infant immune system. Colostrum (days 0-3 
post-delivery) in general has greater levels of all immune components than transitional milk 
(days 4-7) post-delivery and mature milk (> day 7 post-delivery). Significant variations in milk 
immune components associated with maternal conditions fall into two categories: non modifiable 
demographical characteristics (age, race/ethnicity, origin of maternal birth), and modifiable 
characteristics (type of delivery, maternal health, diet, health behaviors) (Agarwal et al., 2011; 
Thibeau & D'Apolito, 2012). Methodological issues that may contribute to the reported 
variations in milk immune cell levels include small sample sizes and differences in sample 
collection and analyses. Small sample sizes are related to feasibility issues of recruitment and 
collections. Differences in methods of collection such as (1) at the beginning or end of a feed, (2) 
pooled sample from several pumpings, (3) time of day of the collection, or (4) day post-delivery 
influences the milk immune cell levels making it difficult to delineate a trend.  Variations in milk 
immune components that appear to be influenced by maternal conditions such as stress are 
important to explore for the science of milk defines milk as not just the best nutrition, but the 
best protection for infant health.  
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Role of Milk in Infant Health 
The biological function of immune components in milk is to protect the infant post-
delivery (Agarwal et al., 2011; Brandtzaeg, 2010). Infants are born with a natural innate immune 
system that functions to generate an immune response but the specific response (pro-
inflammatory/anti-inflammatory) is not fully developed (Lawrence &  Pane, 2007; Newburg, 
2005). Human milk immune components have the ability to interact directly with the infant 
mucosal linings of the respiratory and/or gastro-intestinal tracts by stimulating infant immune 
cell responses (Agarwal et al., 2011: Brandtzaeg, 2010). The infants’ immune memory as a result 
of this interaction is strengthened for life.  
Within milk, SIgA and probiotics function to facilitate the development of the acquired 
immune system in infants (Brandtzaeg, 2003; Newburg, 2005). The maternal transfer of 
antibodies across the placenta to the fetus occurs around 34 weeks gestation (Brandtzaeg, 2003; 
2010). This serves to provide the infant with initial immune protection post-delivery. Once the 
mother/infant dyad spend time together post-delivery, the mothers mucosal associated lymphoid 
tissues (MALT) absorb bacteria/pathogens in the mother infant environment to create specific 
antibodies against these pathogens which is then transferred to the infant via human milk. This 
process may take 24-48 hours therefore components of the innate immune system (cytokines) 
serve as the front-line protection (Newburg, 2005). The cytokines within the infant’s innate 
immune system may have naïve capabilities, thus the maternal cytokines within human milk 
educate the immature infant cytokines to protect the intestinal mucosa and recognize or tolerate 
friendly bacteria essential for digestion (Field, 2005; R. Garofalo, 2010; Goldman, 2007). This 
milieu of immune cells and bacteria within the intestine is known as the intestinal microbiome.  
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It is postulated that the intestinal microbiome is responsible for maintaining a healthy 
equilibrium within the host intestines and also for mounting the appropriate immune response to 
promote intestinal health (Murgas Torazza & Neu, 2011). The intestinal microbiome can be 
manipulated by mode of delivery and breastfeeding. Post-vaginal delivery, the healthy term 
infants’ intestinal flora is colonized with maternal bacteria such as lactobacillus and 
bifidobacterium which serve as probiotics that aid indigestion. Post-cesarean section delivery, 
the infant bypasses this exposure and derives exposures from non-maternal bacteria which 
creates a less diverse microbiome. Human milk contains probiotics, prebiotics, antibodies and 
immune components that together influence the infant intestinal microbiome thus breastfeeding 
is the next best bridge to developing a healthy microbiome environment. New science is linking 
the developing intestinal microbiome to health and disease during infancy and beyond (Murgas 
Torazza & Neu, 2011). 
In a meta-analysis of breastfeeding and infant outcomes in developed countries, 43 
studies identified the associations between breastfeeding and infant outcomes (Ip et al., 2007). 
Infants ever breastfed had lower odds of developing adverse outcomes, especially hospitalization 
for respiratory tract infections, and gastrointestinal infections including diarrhea than infants 
exclusively fed formula. See Table 11 for a summary of the outcome data. 
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Table 11: Outcomes of Infants Breastfed at least 3 Months 
Outcome Odds Ratio 95% CI 
Acute otitis media 0.60 0.46, 0.78 
Atopic dermatitis  0.68 0.52, 0.88 
Gastro-intestinal infections including diarrhea  0.36 0.32, 0.80 
Hospitalization for lower respiratory tract infections during 
the first year of life 
0.28 0.14, 0.54 
Asthma during the first 2 years of life 0.70 0.60, 0.81 
Obesity between 5-18 years 0.67 0.62., 0.73 
Type 1 diabetes between10-16 years  0.36 0.14, 0.94 
Type 2 diabetes in adolescents and adults 0.61 0.44, 0.85 
Acute lymphocytic leukemia 0.80 0.71, 0.91 
Sudden infant death syndrome  0.79 0.67, 0.93 
 
Clearly breastfeeding assists in developing the infant immature immune system by 
providing both acquired and innate immune support/instruction that impacts infant outcomes 
through the first year of life. Priming the intestinal microbiome with immune instructions from 
breastmilk immune cells reduces the odds of illnesses within the first year of life as well as long-
term co-morbidities such as obesity and diabetes. Even though maternal stress may impact infant 
immune response shortly after birth, it is not yet known if maternal stress alters milk immune 
cells enough to impact infant health during the first year of life and beyond.  
Definitions of Terms 
The primary aims of this study were to explore the relationships among the following 
variables of interest: AA mothers of term infants, demographics of infants, maternal stress 
indicators, salivary cortisol, and milk immune components. See below for the conceptual and 
operational definitions of these variables. 
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Table 12: Conceptual and Operational Definitions of Study Variables 
Variable  Conceptual Definition Operational Definition 
1. AA Mothers 
of Term 
Infants  
 
Mothers who self-report 
AA race and deliver viable 
infants ≥ 37 weeks 
gestation (March of Dimes, 
2010). 
Mother declares AA race on medical record, 
infant gestation ≥ 37 weeks in medical record 
2. Maternal 
Stress 
Indicators 
The physical, 
psychological, and 
environmental factors that 
influence the 
psychobiological 
processing of perceived 
stress (Ader, Cohen & 
Felten, 1995; Lazarus and 
Folkman, 1984). 
Maternal physical characteristics (age, race,  
number of previous pregnancies, mode of 
delivery, smoking, infection, diabetes [self-
report], hypertension [self-report]; psychological 
characteristics (summed score of the perceived 
stress scale); and environmental characteristics 
(relationship status, number of children cared for, 
and socioeconomic status- private insurance, 
Medicaid, self-pay)  
 
3. Salivary 
Cortisol 
Cortisol in saliva (ng/mL) 
is a responsive 
measurement of self-
perceived stress and is best 
described using diurnal 
samples (Nicholson, 2008). 
The laboratory assays of salivary cortisol on Day 
9 (upon awakening, 30 and 60 minutes after 
awakening known as the cortisol awakening 
response or CAR). Cortisol will be reported 
using ng/mL. Area under the curve will be 
calculated for the CAR.  
 
4. Milk immune 
components 
The components in human 
milk that provide anti-
inflammatory, pro-
inflammatory protection for 
the receiving infant 
(Goldman, 1993). 
The laboratory assays of milk SIgA, EGF, TNF-
α, IL-4, IL-6, IL-8, IL-10, IP-10, MCP-1, MIP-
1α on days 3, 9, and 14 post-delivery. Self-report 
of the number of feedings/day to estimate 
immune components/volume of feeding 
 
5. Infant 
Demographics  
Infant Birth Weight and 
Gestational Age are used to 
describe infant 
demographics across 
populations (March of 
Dimes, 2010).  
Birth Weight measured in grams, 
Gestational Age on day of delivery  as measured 
by prenatal ultrasound in weeks/days since 
gestation 
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CHAPTER 3 
 
METHODOLOGY 
 
Design 
A descriptive study with a longitudinal design was used to explore the relationships 
among maternal stress indicators and milk immune components on days 3, 9, and 14 post-
delivery. The rationale for this design was based on: (1) the known impact of self-perceived 
stress on the immune system function and overall health over time, and (2) the natural variation 
of milk immune components during the first two weeks post-delivery (Agarwal et al., 2011; 
Elenkov & Chrousos, 2002; Segerstrom & Miller, 2004). Prospective longitudinal cohort designs 
provide the opportunity for multiple measurements within the same panel of participants which 
strengthens internal and external validity by providing opportunities to observe individual 
changes in dependent outcomes over time and reducing multiple cohort effects by using the same 
group of participants (de Vaus, 2001).  
Setting 
The research setting was a quaternary teaching hospital in the New Orleans metropolitan 
area. This facility delivers over 2,500 term infants /year. Infants stay with the mother on the 
Mother baby unit if both the mother and infant are healthy post-delivery. There is a Regional 
Level III Neonatal Intensive Care Unit on site for infants that need specialized services.   
Sample and Sampling Plan 
 Sample enrollment was projected to be 100 participants given a 20% drop-off rate based 
on a prior feasibility study, and a minimum of 75 participants which is required to achieve 
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statistical significance (80% statistical power, alpha=0.050) for a 0.30 correlation (small), and 
associations with shared variability of at least 10% (Malgady & Krebs, 1986). To reduce the 
response variability due to racial differences, only AA women were recruited.  
Study inclusion criteria including the following:   
 maternal age ≥18 
 delivery of a viable term infant with 5 minute Apgar score ≥ 7, gestational age  ≥37 
weeks, and a birth weight ≥ 1800 grams 
 able and willing to provide written informed consent 
 able  and willing to provide human milk samples  
Study exclusion criteria included the following:  
 known drug addiction 
 placental abruption  
Methods for Participant Recruitment 
All AA mothers who delivered healthy term infants in the research setting were 
approached by the lactation consultant team within 24 hours post-delivery. The lactation team 
presented the study flyer to the mother describing the study (see Appendix A). If the mother 
expressed interest, the lactation team notified the principal investigator of a potential participant 
or the potential participant called the principal investigator directly on the phone using the 
number provided.  The principal investigator used the electronic medical record to ascertain 
inclusion/exclusion criteria information. The principal investigator or study staff approached all 
mothers meeting eligibility criteria within 72 hours post-delivery to further describe the study 
and answer any study related questions. It was estimated that greater than 90% of mothers 
approached would agree to participate in this study based on previous experiences in a feasibility 
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study where 100% women approached gave informed consent and 100% recommended this type 
of research study to other mothers (Thibeau & D'Apolito, 2011).  
Human Participant Protection 
Human participant protection was provided in accordance with the guidelines set forth by 
the Office of Research Integrity and Title 45 of the Code of Federal Regulations, Part 46 (45CFR 
46), Subpart A-C. The research consent met these requirements (see Appendix B). The principal 
investigator contact information was given to all participants on the consent form. Once consent 
was signed, an individual participant ID was assigned to the participant. All mothers received the 
standard lactation services provided by the institution at all times regardless of participation in 
this study. Should the study participant report any issues related to pumping such as sore, 
cracked nipples, lumps, and/or fever during communication with the principal investigator or 
study staff, the mother was referred to the lactation and/or medical team for assessment and 
treatment. 
The provision of social services, a standard of care for all mothers post-delivery, was 
available for all study participants as part of their routine healthcare services. The principal 
investigator and study staff were responsible for notifying social services should individual self-
reported psychosocial issues arise.   
All milk and cortisol samples were pre- labeled with the participant ID number and the 
day of collection. Participants were informed that the frozen milk and saliva samples would be 
stored in a biobank freezer for future data analysis in a secured storage in the lab designated by 
the institution of IRB record. The principal investigator and study staff had access to the 
participants’ medical record numbers (MRN) during data collection; the link between MRN and 
participant ID were stored on an encrypted computer of the principal investigator in a locked 
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office only accessed by the principal investigator. All demographic and survey data collected 
were archived in REDCap™, a secure electronic storage site of Vanderbilt University 
(Vanderbilt University, 2014). Biological data was stored on an encrypted computer of the 
principal investigator. Participants were informed that their participation was voluntary and that 
they could withdraw from the study at any time. Participants were also informed that there was 
no direct benefit to the mother or infant by participating in this study but the knowledge gained 
from this study may benefit future mothers and their infants. A $ 25 gift card was given to the 
participants when all study materials were received by the principal investigator. 
 
Data Collection and Analysis 
Measurements and Instruments 
The following instruments and measurements were used for data collection: 
1. Mothers’ Survey –the self-report of maternal characteristics such as age, ethnicity, race, brief 
physical-social history that was relevant for this research (see Appendix C). Data points 
chosen were selected to increase external validity of the sample of mothers.   
2. Perceived Stress Scale- The Perceived Stress Scale (PSS) is a 14 item instrument with Likert 
type response options ranging from 0-4 (0= never and 4= very often). A summed score was 
created by reversing the scores on the seven positive items (items 4, 5, 6, 7, 9, 10, and 13), 
e.g., 0=4, 1=3, 2=2, etc., and then summing across all 14 items (see Appendix D) (Cohen et 
al., 1983).  
3. Maternal-Infant Data Collection Sheet -the following variables on each mother/infant dyad 
were obtained from the medical record (see Appendix E):  
a. Infant gender (nominal) - male, female 
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b. Infant birth weight (ratio) -first weight post-delivery in grams 
c. Gestational age (GA) (ratio) -reported GA on day of delivery determined by using the  
obstetrical estimate since last menstrual period and or prenatal ultrasound 
d. Infant length of stay (ratio) - calculated by the numbers of consecutive days 
hospitalized post-delivery 
e. Maternal diabetes - last HbA1C documented in the medical record of the mother 
f. Maternal blood pressure (interval)- last blood pressure documented in the medical 
record of the mother 
g. Volume of human milk feedings (ratio)- number of times infant breastfed or breasts 
pumped per day on Days 3, 9, and 14 post-delivery 
4. Salivary Cortisol- Participants were given detailed instruction on collection and storage of 
saliva (see Appendix F). Saliva was collected from the participant after Day 14 of study 
procedures and stored in the biobank freezers (-20º C) of the institution of IRB record then 
bulk shipped overnight to the Vanderbilt Clinical Research Core lab for analysis using 
ELISA assay kits purchased from ALPCO which uses an immune-enzymatic colorimetric 
method for quantitative determination of cortisol concentration in saliva.  
a. The preparation of the quality controls, wash buffer, and substrate were prepared 
according to the manufacturer’s instructions. 
b. The previously frozen saliva samples were defrosted and centrifuged at 3000 rpm for 
10 minutes; the clear saliva (separated from precipitants by the centrifuge) was used 
in the analysis.  
c. 20 µl of standards, controls, and saliva samples were pipetted to appropriate wells on 
each plate 
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d. 100 µl of conjugate (antibody) was added to each well 
e. The plates were incubated on a horizontal plate shaker for 45 minutes at room 
temperature (15-30º C) 
f. The wells were washed 3x with 300 µl of wash buffer and the plates were then tapped 
firmly against absorbent paper to ensure the plates were dry 
g. 150 µl of substrate solution was pipetted into each well at timed intervals 
h. The plates were incubated on a horizontal plate shaker for 15-20 minutes at room 
temperature (15-30º C) or until calibrator A turned a dark blue color 
i. The wells were aspirated and washed 5x with 250 µl of ELISA wash buffer 
j. 50 µl of ELISA stop solution was added to each well at the same timed intervals as in 
step c 
k. Using an ELISA reader at 450 nm the absorption was determined immediately 
To calculate the saliva values, the mean optical density was calculated and used to build a 
calibrator curve with the mean optical densities on the Y-axis and the calibrator 
concentrations on the x-axis. Control samples were analyzed for each run, those results 
outside the quality control values were reported as not valid (QNS). Results within the 
quality controls values were reported in ng/mL. 
5. Milk measurements- Participants were given detailed instruction on the collection and 
storage of milk (see Appendix G). Milk was collected from participants after Day 14 of study 
procedures and stored in the biobank freezers (-80º C) of the institution of IRB record then 
bulk shipped overnight to the Biobehavioral lab at the University of South Florida for 
analysis. The previously frozen milk samples were defrosted then centrifuged at 5000 rpm 
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for 5 minutes. The fat layer was manually removed and the whey filtered before the sample 
was aliquotted into Eppendorf tubes and stored at – 80° C until analysis.  
a. Milk cytokines/chemokines (EGF, IL-4, IL-6, IL-8, IL-10, TNF-α, IP-10, MCP-1, 
MIP-1α) were measured in a Luminex MAGPIX instrument using a Milliplex MAP 
Kit purchased from EMD Millipore Corporation. The kit contained fluorescent-coded 
magnetic beads (microspheres) with antibody capture that bind with the individual 
cytokines/chemokines.  
b. The preparation of the quality controls, wash buffer, matrix and human cytokine 
standards followed manufacturer instructions.  
c. The plates were prepared using the following procedures 
i. 200 µl of wash buffer was added to each well then placed on horizontal plate 
shaker for 10 minutes at room temperature (15-30ºC) 
ii. The plates were inverted on an absorbent surface and gently tapped to drain 
the wells, 25 µl of standard or control was added to appropriate wells, 25 µl 
assay buffer to background and sample wells, 25 µl of matrix solution to 
background, standards and controls wells, 25µl of samples to sample wells, 
and 25 µl of beads to each well after vortexing bead bottle to suspend beads.   
iii. The plates were sealed with foil and incubated overnight (16-18 hours) on a 
horizontal plate shaker at 4ºC 
iv. The plates were inverted and tapped on absorbent surface to remove residual 
amount and then the wells were washed 2x with 200 µl of wash buffer (plates 
were inverted to drain after each wash) 
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v. Next, 25 µl of detection antibodies were added to each well, the plates were 
sealed with foil and  incubated on a horizontal plate shaker for one hour at 
room temperature (15-30ºC)  
vi. The plates were not aspirated. Next, 25 µl of Streptavidin-Phycoerythrin was 
added to each well, then the plates were sealed with foil and  incubated on a 
horizontal plate shaker for 30 minutes at room temperature (15-30ºC) 
vii. The plates were inverted to drain well contents on absorbent surface and then 
150 µl of drive fluid was added to each well, then the plates were placed on 
horizontal plate shaker for 5 minutes 
d. The prepared plates were then placed in the MAGPIX where the microspheres were 
passed through a laser which stimulated a specific fluorescent dye on each 
microsphere. A high speed digital processor identified each microsphere and 
quantified each cytokine/chemokine assay. Control samples were analyzed for each 
run and those values outside the controls were reported as not valid. Values were 
reported as pg/mL. When the value was below the limit of detection (LOD), half the 
value was used between 0 and LOD. When the value was above the limit of detection, 
the average of the values was used.    
6. The milk SIgA was measured using an ELISA kit purchased from ALPCO.  
a. The assay plates were prewashed 5x with 250 µl ELISA wash buffer before use. The 
whey milk (separated from fat ) was diluted in ELISA wash buffer to create a final 
dilution of 1: 60,000 for Plate 1; 1:150,000 for Plate 4; and 1:200,000 for Plates 2, 3, 
5, and  6 using the following steps:  
i. 1:60,000 dilution  
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1. 5 µl milk sample + 495 µl wash buffer mixed well= dilution 1 (1:100) 
2. 5 µl Diluent 1+495 µl wash buffer = dilution 2 (1:100) 
3. 84 µl Diluent 2+416 µl wash buffer=Final solution to load onto plate 
(1:6)  
ii. 1: 150,000 dilution 
1. 5 µl milk sample + 495 µl wash buffer mixed well= dilution 1 (1:100) 
2. 5 µl Diluent 1+495 µl wash buffer = dilution 2 (1:100) 
3. 15 µl Diluent 2+475 µl wash buffer=Final solution to load onto plate 
(1:15)  
iii. 1:200,000 dilution 
1. 5 µl milk sample + 495 µl wash buffer mixed well= dilution 1 (1:100) 
2. 5 µl Diluent 1+495 µl wash buffer = dilution 2 (1:100) 
3. 25 µl Diluent 2+475 µl wash buffer=Final solution to load onto plate 
(1:20)  
b. 100 µl of standards and controls were added to appropriate wells, then incubated for 
one hour on a horizontal mixer at room temperature.  
c. The wells were then aspirated and washed with 250 µl ELISA buffer. In each well, 
100 µl of conjugate were added and incubated for one hour on a horizontal shaker at 
room temperature.  
d. The contents of the plate were removed and the wells were washed 5 times 250µl 
wash buffer using a plate washer and 100 µl of substrate was added before the final 
incubation for 10-20 minutes at room temperature.  
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e. An ELISA stop solution (100 µl) was added to the wells and using a photometer the 
SIgA was quantified. SIgA were reported as mg/mL. 
In a previous feasibility study, the University of South Florida (USF) College of Nursing 
Biobehavioral Lab was used to process the samples of milk from mothers of preterm infants 
collected on Day 7 post-delivery (Thibeau & D'Apolito, 2011). The majority of the milk values 
from the feasibility study fell within ranges of milk analyzed at the USF lab (see Table 13) thus 
the USF lab was used for the analyses of milk samples from this study.  
Table 13: Comparison of Milk Immune Components in Preterm Milk Analyzed at USF  
 TNF 
Median 
(Range) 
IL-4 
Median 
(Range) 
IL-6 
Median 
(Range) 
IL-8 
Median 
(Range) 
IL-10 
Median 
(Range) 
IP-10 
Median 
(Range) 
MCP-1 
Median 
(Range) 
Thibeau & 
D’Apolito 
(2011) 
16.6 
(9, 90) 
1.6 
(1.6, 2.8) 
2.2 
(0.8, 73.5) 
64.7 
(0.8, 139) 
0.8 
(0.8- 4) 
0.8 
(0.8, 6288) 
0.8 
(0.8) 
 M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) M (SD) 
Groer- 
unpublished 
(2014)  
20.3 
(18.3) 
12.9 
(29.2) 
22.9 
(28) 
475 
(2241.2) 
11.9 
(23.1) 
1971.5 
(2968.3) 
2047.2 
(2559.8) 
Note: Values reported as pg/mL.  
Procedures 
The principal investigator met with the study staff to review training and procedures prior 
to enrolling participants (see Appendix H). Training included orientation to the following: 
presentation of study flyer to potential participants (see Appendix A), orientation to the consent 
process and consent form (see Appendix B), Maternal-Infant Data Sheet (see Appendix E), 
participant participation packet which included all necessary instructions (see Appendices F and 
G), and supplies required to participate in this study. A phone number to reach the principal 
investigator was given to each study staff and the nursing manager of the Mother-Baby Unit 
should any questions arise. This information was also written on the consent and instruction 
materials. 
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 The principal investigator or study staff explained the purpose and details of the study to 
the participants and obtained the written informed consent. The written consent was obtained 
before the participants were discharged from the hospital. A signed copy of the consent was 
given to the participants and they were instructed to keep the copy with their personal records. 
All enrolled participants received a kit which included the following: 
1. The collection, storage and transport of milk samples and survey instructions (see Appendix 
G)  
2. Three small milk collection containers with study ID labels  
3. The collection, storage and transport of saliva samples instructions (see Appendix F) 
4. Three salivette collection containers with study ID labels 
5. One paper copy of the Mothers’ Survey (Appendix C)  
6. Three paper copies each of the Perceived Stress Scale (Appendix D) labeled with study ID 
labels and day to respond 
7. One envelope labeled with study ID label  
8. One pen  
9. A milk transport bag with icepack, and microwave sterilization kit for pumping supplies   
The principal investigator or study staff instructed each participant on the proper 
collection, storage and handling of milk and saliva as well as transportation of the samples to the 
principal investigator.  On collection days  3, 9 and 14 post-delivery, the enrolled participants 
were instructed by the principal investigator or study staff to do the following: (1) wash hands 
before pumping and/or handling milk; (2) pump both breasts and pour the colostrum/milk into a 
sterile container and place the container into a refrigerator; (3) place approximately 5 ml into the 
study container marked with study ID/date; (4) place the study milk sample in a home freezer; 
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(5) complete each of the perceived stress scales as instructed and place in the envelope provided; 
(6) complete the Mothers’ Survey on any day of collection  and place in the envelope provided; 
(7) collect saliva samples on Day 9 following instructions; (8) bring the completed surveys and 
the milk samples to the principal investigator at the mutually scheduled time and location.  
Sample storage freezers (-80 º C for milk and – 20 º C for saliva) within the research 
settings were provided with emergency back-up electrical generators.  A 24/7 telephone number 
to reach the principal investigator was placed on the outside of the freezer storage containers so 
that bio-bank could call at any time for any issues/concerns with stored samples. The stored milk 
samples were shipped overnight to the Biobehavioral Laboratory at University of South Florida 
in Tampa, Florida.  The stored saliva samples were shipped overnight to the Clinical Research 
Center lab at Vanderbilt University, Nashville, Tennessee. Shipments were packed in dry ice 
pellets, labeled according to shipping guidelines, and received by respective labs the following 
morning. Confirmation of shipment integrity upon arrival was confirmed by the laboratory 
technicians in each receiving lab.  
Data Preparation  
 All data were entered into REDCap™, the secure research electronic data capture storage 
web-portal of Vanderbilt University. Data files from REDCap™ were then downloaded and 
entered into SPSS V 18 on the principal investigator’s encrypted computer.  Only the principal 
investigator had identification access to this computer. All data sheets and the individual surveys 
were stored in a locked cabinet within the principal investigators office. When all data analysis 
was complete, the individual surveys and data collection sheets were transferred to the secure 
storage of the IRB of record. All data files and analysis results were stored on the principal 
investigator’s encrypted computer for the duration of analysis.  
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Missing Data 
 A complete data set per subject was defined as the following: completed Mothers Survey, 
PSS for Day 3, 9, and 14, milk samples on Day 3, 9, and 14, and saliva samples on Day 9. 
Incomplete surveys and biological specimens that were not sufficient for analysis were not 
included in the study analyses of Aims 1 and 2. A biological specimen was considered sufficient 
for analysis if there was enough milk or saliva within the collection container to use in the assay 
tests (quantities were determined by the laboratory technicians) and the values fell within the 
quality controls of the assay test.  
Data Analysis  
General 
 Demographic and static maternal stressor data were collected at the beginning of the 
study. Subsequently, the Perceived Stress Scale (PSS), breast milk SIgA and cytokine/chemokine 
(C/C) content were collected on days 3, 9 and 14 postpartum. On day 9 a salivary sample was 
collected to analyze cortisol content. Cronbach’s alpha statistics were generated to measure the 
internal consistency of the PSS responses at each time of assessment.  
Descriptive statistics were used to summarize and assess the distributional characteristics 
of all study variables. Milk (SIgA, C/C) and salivary cortisol values were positively skewed. The 
square root transformation of these variables resulted in suitable distributions for use in 
parametric statistical analyses. The validity of the collected milk components (i.e., that the 
pattern of change was consistent with expectations) was assessed using mixed-level general 
linear models. Initially an overall test of differences among the 3 days of collection was 
conducted. If the overall test was statistically significant, post-hoc pairwise tests using a 
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Bonferoni-corrected alpha were conducted. Unless specifically noted, an alpha of 0.05 was used 
to determine the statistical significance of any results.  
Demographic and stress indicator data from those enrolled who completed the study 
compared to those who did not complete the study were compared (see Figure 6 for description 
of sample used in analysis). Chi-Square Tests of Independence were used to test for differences 
in the nominal data. Mann-Whitney Tests were performed to test for differences in the 
continuous data.  
Analysis Specific to Aim 1 
Pearson correlations were used to assess the correlations among the study variables on 
each day of collection. Three matrices were generated for each day: (1) age, number of previous 
pregnancies, mode of delivery, smoking, antibiotics received during pregnancy, diabetes, 
hypertension, number of children under care, private insurance, Medicaid, self-pay, and 
relationship status; (2) PSS with matched milk immune components (SIgA, C/C) on each day; 
and (3) milk SIgA, EGF, IL-10, IL-4, IL-6, IL8, IP-10, MCP-1, MIP-1α, and TNF-α on Day 3, 
Day 9, Day 14. For Day 9, the addition of salivary cortisol was included.  
Pearson correlations were used to assess the correlations of study variables on Day 3 with 
Day 14. A new milk change variable was created by subtracting the Day 14 values from Day 3 
values. The milk change values were rank transformed to obtain normal distributions except IL-
6, IP-10, and MCP-1 which were normally distributed. A linear regression was used to assess 
correlations of study variables on Day 3 with Day 14 controlling for the milk values of Day 3.   
Multiple linear regressions were used to assess previously reported maternal stress 
indicators as a single model on levels of milk immune components by day post-delivery. Pearson 
correlations were used to assess the correlations of maternal stress indicators with salivary 
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cortisol. Associations for Aim 1 were considered to be clinically meaningful if they indicated at 
least 10% variance shared (i.e. r (unadjusted) or beta (adjusted) =0.33).  
Analysis Specific to Aim 2 
Multiple linear regressions were used to assess the meditational effect of maternal 
cortisol on the association of maternal self-reports of maternal stress with immune components. 
This proposed mediational effect is illustrated in Figure 5. The bolded, single-ended arrows 
illustrate a proposed mediational path of cortisol.  The estimate of the degree to which cortisol 
mediates the relationship between maternal stress self-report and milk immune components is the 
estimate of the overall indirect effect of maternal stress on immune components (e.g., path: a12 
[PSS-cortisol] +b23 [cortisol-milk]); an estimate of the respective overall direct effect of maternal 
stress on immune components (without cortisol mediation) is the direct path (e.g., c13 [PSS-
milk]).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5:  Analytical Strategy for Aim 2 
 
 
 
c13 
b23 
a12 
Maternal Salivary 
Cortisol [T2] 
 
Maternal Self-Report 
of Stress (PSS), T1] 
 
Milk SIgA & 
C/C 
[T3] 
3 Days Post-delivery 9 Days Post-delivery 14 Days Post-delivery 
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CHAPTER 4 
 
RESULTS 
 
 During the 434 days of active enrollment, there were 865 AA term deliveries, of which 
328 (38%) met eligibility criteria and were approached for consent to this study. A total of 139 
(42%) of those women approached consented. Of the 139 women consented, 89 (64%) returned 
study materials and received a gift card valued at $25.00. Four of the 89 women returned 
incomplete surveys. Reasons that contributed to the 36 % attrition rate included: 21.5 % (30/139) 
stopped breastfeeding by Day 9, 8 % (11/139) stopped breastfeeding by Day 14, and 6.5% 
(9/139) were lost to follow-up.  
On day three 72% (n=100) of the participants submitted breast milk samples and 64% 
(n=89) submitted milk samples on days 9 and 14. On day nine 63% (n=88) of the participants 
submitted saliva samples. The number of saliva samples sufficient for lab analysis of cortisol at 
the three collection time periods on Day 9 was 83/88 (94%). The number of milk samples 
sufficient for lab analysis of milk immune components by day of collection included: Day 3= 
63/100 (63%) of SIgA and 68/100 (68%) of cytokines/chemokines (C/C), Day 9=78/89 (88%) of 
SIgA, C/C, and Day 14=74/89 (83%) of SIgA, C/C (see Figure 6). Due to the nonrandom nature 
of the incomplete data, no values were imputed; therefore the data from 85 (61%) women were 
used for data analyses (for details see Figure 6).  
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Figure 6: Summary of Data Variables Used in Analyses of Aims 1 and 2 
 
Descriptive Summaries 
The baseline characteristics of those women who completed the study (N=85) and those 
who did not (N=54) are summarized in Table 14. No statistically significant differences between 
groups were observed. The average age of the mothers was 27.8 years, 51.8% of the infants were 
male, the average infant gestation was 39.3 weeks, median infant birth weight was 3245 grams 
(7.2 lbs), and length of stay for mothers/infants was 3.12 days.  
 
 
Complete Surveys 
N=85 
Cortisol Sufficient for 
Analysis N=83 
Enrolled 
N=139 
Aim 1 
Day 3 N=59 sIgA, N=63 CC 
Day 9 N=73 all milk 
Day 14 N=73 all milk 
Cortisol N=74 
PSS matched to milk by day 
 
 
Aim 2 
sIgA  N=70 
C/C N=70 
Cortisol N=70  
Day 3 PSS matched to milk 
Milks Sufficient for Analysis 
Day 3 N=63 sIgA, N=68 C/C 
Day 9 N=78 all 
Day 14 N=74 all 
Returned Samples and Surveys N=89 
Returned Milk Day 3=100, Day 9=89, Day 14=89 
Returned Saliva Day 9=88 
Attrition N=50 
Stopped breastfeeding Day 9=30 
Stopped breastfeeding Day 14=11 
Lost to follow-up=9 
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Table 14: Sample Demographics 
Note: Independent t-Tests were performed for maternal age, infant gestation, mother infant length of stay; 
Mann Whitney Test was performed for infant birth weight; Chi Square Test of Independence was 
performed for infant gender.   
 
Baseline maternal physical stress indicators of the group of mothers in the study and 
those with inadequate data are summarized in Table 15. Again there were no statistically 
significant differences between the groups. Within the study sample, 64.7% experienced vaginal 
delivery, 34.1 % had no prior pregnancies, 34.1% received antibiotics, 7.1% reported 
hypertension and diabetes, and 3.5% reported smoking.  
Table 15: Summary of Maternal Physical Stress Indicators 
 Inadequate Data=54 
 
Study Sample=85 
 
P Value 
 N (%) N (%)  
Number of Previous Pregnancies   0.832 
     0 16 (29.6) 29 (34.1)  
     1 18 (33.3) 28 (32.9)  
      =>2 20 (37.0) 28 (32.9)  
Mode of Delivery   0.835 
     Vaginal 34 (63.0) 55 (64.7)  
     Cesarean section 20 (37.0) 30 (35.3)  
Smoking Unknown 3 (3.5)  
Infection- received antibiotics Unknown 29 (34.1)  
Hypertension  Unknown 6 (7.1)  
Diabetes Unknown 6 (7.1)  
Note: Chi Square test of Independence was performed on Number of Previous Pregnancies and Mode of 
Delivery 
 Inadequate Data= 54 Study Sample= 85 
 
P Value 
 M (SD) Mdn (IQR) M (SD) Mdn (IQR)  
Maternal Age- years 26.6 (5.8)  27.8 (4.7)  0.165 
Infant Birth Weight- 
grams 
 3220 
(2994,3511) 
 3245 
(3015,3713) 
0.696 
Infant Gestational 
Age- weeks 
39.6 (1.0)  39.3 (1.1)  0.100 
Mother/Infant Length 
of Stay- days 
3.24 (0.6)  3.14 (0.5)  0.267 
 N (%) N (%)  
Infant Gender   0.387 
     Male 32 (59.3) 44 (51.8)  
     Female 22 (40.7) 41 (48.2)  
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Maternal self-perceived stress (PSS) summed scores on Days 3, 9, and 14 are 
summarized in Table 16. There were no statistically significant differences in the self-report of 
perceived stress between groups.  
Table 16:  Summary of Maternal Psychological Stress Indicators 
 Inadequate Data=54 
 
Study Sample=85 
 
P 
Value 
PSS Summed Scores N Mdn (IQR) N Mdn (IQR)  
     Day 3  22 20 (14,28) 63 16 (10,21) 0.099 
     Day 9   11 14 (10,25) 74 19 (12,26) 0.699 
     Day 14  11 24 (11,30) 74 18 (11,26) 0.463 
PSS Items  Cronbach’s alpha  Cronbach’s alpha  
     Day 3  22 0.92 63 0.88  
     Day 9   11 0.89 74 0.89  
     Day 14  11 0.93 74 0.89  
Note: Mann Whitney Tests were performed. 
Baseline maternal environmental stress indicators of the group of mothers in the study 
and those with inadequate data are summarized in Table 17. Again there were no statistically 
significant differences between the groups. Approximately 46 % of the study sample was 
married, 52.9% cared for at least one child, and 63.5% reported Medicaid enrollment.  
Table 17:  Summary of Maternal Environmental Stress Indicators 
 Inadequate Data=54 
 
Study Sample=85 P Value 
 N (%) N (%)  
Number of Children in Care    0.900 
     1 28 (51.9) 45 (52.9)  
     ≥2 26 (48.1) 40 (47.1)  
Insurance Status    
     Private Unknown 49 (57.6)  
     Medicaid Unknown 54 (63.5)  
     Self Pay Unknown 3 (3.5)  
Relationship Status        
Single Unknown 23 (27.1)  
Married Unknown 39 (45.9)  
W/Partner Unknown 23 (27.1)  
Note: Chi Square Test of Independence was used for Number of Children in Care.  
 Baseline salivary cortisol values of the group of mothers in the study sample and those 
with subsequent inadequate data are summarized in Table 18. There were no statistically 
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significant differences between the groups. The peak cortisol value of mothers in the study 
sample (all African American) was at the 30 minutes post awake time period. This finding 
replicates similar findings reported in the literature with heterogenous racial groups describing 
the  peak morning cortisol awakening response (CAR) being 30-45 minutes post awakening 
(Adam & Kumari, 2009; Fekedulgen et al., 2007).   
Table 18: Summary of Cortisol Values 
 Inadequate Data=9 
 
Study Sample=73 
 
P Value 
 Mdn (IQR) Mdn (IQR)  
Salivary Cortisol    
     Awake 11 (7.7,38.2) 19 (11.4, 25.0) 0.598 
     30 minutes  16 (5.3,35.0) 21 (12.3, 30.0) 0.372 
     60 minutes  18 (8.4,30.0) 18 (10.0, 27.0) 0.694 
AUC 30 (13.7, 67.8) 40 (24.3, 53.1) 0.501 
Note- Values reported as ng/mL; Mann Whitney Tests were performed. 
Milk immune component values are summarized in Table 19 below. The ranges on all 
three days of collection fell within those in the published literature (see Table 1 and Table 19).  
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Table 19: Summary of Milk Immune Component Values 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note- SIgA is reported as mg/mL, all other values reported as pg/mL. 
  
 
 
 
 Final Analysis Set 
 
 N Mdn (IQR) 
Day 3  
SIgA  59 24.4 (11.2, 46) 
EGF 63 8542 (6350, 12436) 
IL-10 63 3.8 (1.2, 13.4) 
IL-4 63 1 (0.37, 1.6) 
IL-6 63 35 (17.1, 71.1) 
IL-8 63 144 (63, 738.5) 
IP-10 63 1392 (716, 2442) 
MCP-1 63 532 (148.8, 1386) 
MIP-1α 63 63.2 (29.7, 199) 
TNF-α 63 29 (15.7, 39) 
Day 9 
SIgA 73 13.3 (5.5, 16) 
EGF 73 11696 (6732, 13491) 
IL-10 73 1.4 (0.82, 5.7) 
IL-4 73 0.6 (0.37, 1.6) 
IL-6 73 14 (5.2, 32.4) 
IL-8 73 33.2 (7.2, 98) 
IP-10 73 1539 (739, 2552) 
MCP-1 73 558 (132.5, 2345) 
MIP-1α 73 12.8 (4.7, 33.5) 
TNF-α 73 16.4 (8.7, 30) 
Day 14 
SIgA 73 12.5 (6, 17.8) 
EGF 73 12087 (6732, 14227) 
IL-10 73 1.7 (0.73, 4.5) 
IL-4 73 1 (0.37, 1.6) 
IL-6 73 12.3 (5.2, 33) 
IL-8 73 35 (7.5, 109) 
IP-10 73 1165 (630, 2108) 
MCP-1 73 336.2 (113, 1016.4) 
MIP-1α 73 12.5 (5.5, 46) 
TNF-α 73 15.7 (11, 27) 
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Validity of Milk Overall Changes by Day Post-Delivery 
Milk immune component overall changes by day post-delivery are summarized in Table 
20 below. There were statistically significantly decreased levels of SIgA, IL-6, IL-8, IL-10, MIP-
1α and TNF-α from Day 3 -Day 9 and from Day 3- Day 14; these differences were not 
statistically significant from Day 9-Day 14. There were statistically significant increased levels 
of EGF from Day 3 -Day 9 and from Day 3-Day 14.  There were no statistically significant 
changes in milk values of IL-4, IP-10, and MCP-1 between Days 3, 9 and 14 (see Table 20). 
Table 20: Summary of Milk Overall Changes by Day Post-Delivery 
Milk 
 
 Day 3 
 
 Day 9 
 
 Day 14 
 
Overall  
p-value
 a
 
Post-Hoc
 b
 
 N Median 
(IQR) 
N Median 
(IQR) 
N Median 
(IQR) 
  
SIgA 48 26.2 
(10.5-47.8) 
48 9.3 
(5.5-15.7) 
48 10.5 
(6.1-20.6) 
<0.001 Day 3 > 9,14 
EGF 51 9189 
(6731-12435) 
51 11697 
(6732-12437) 
51 12436 
(6974-14285) 
0.001 Day 9, 14 > 3 
IL-10 51 4.6 
(1.3-13.8) 
51 1.4 
(0.8-3.3) 
51 1.6 
(0.7-4.2) 
<0.001 Day 3 > 9,14 
IL-4 51 1 
(0.4-1.6) 
51 0.7 
(0.4-1.6) 
51 1 
(0.4-1.6) 
0.560  
IL-6 51 38.5 
(18.8-81.8) 
51 16.6 
(5-35) 
51 12.6 
(5-40.2) 
<0.001 Day 3 > 9,14  
IL-8 51 163.4 
(63.1-739) 
51 31.7 
(6.8-97) 
51 34.8 
(7.5-97.7) 
<0.001 Day 3 > 9, 14 
IP-10 51 1392 
(763-2498) 
51 1087 
(575-2317) 
51 1164 
(633-2138) 
0.327  
MIP-1α 51 61.4 
(29.7-199.8) 
51 12.7 
(4.9-32.6) 
51 12.5 
(6.4-49.2) 
<0.001 Day 3 > 9,14 
MCP-1 51 729.4 
(198.5-1977) 
51 475 
(108.4-2549) 
51 352 
(122-891.5) 
0.168  
TNF-α 51 29.5 
(15.1-39.5) 
51 15.2 
(8.6-26.6) 
51 16.1 
(11.5-28.3) 
<0.001 Day 3 > 9,14 
Note: 
a
= Friedman test; 
b
=  Wilcoxin signed rank, statistical significance adjusted using bonferonni 
correction 0.05/3(days)=0.017.  
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Analysis of Hypotheses 
Aim 1  
Assess the associations of maternal stress indicators with specific milk immune 
components (antibodies, cytokines, and chemokines) from AA mothers of term infants during the 
first 14 days post-delivery.  
 Day 3 
Summaries of the association of maternal stress indicators with milk immune components 
on Day 3 post-delivery are summarized in Table 21.  
Physical Stressors. Four out of the seven physical stressors measured in this study were 
statistically significantly associated with levels of milk immune components on Day 3. Lower 
levels of EGF were observed in women who had received antibiotics (r=-0.29, p=0.024) than 
those who had not, as well as in those women who self-reported a diabetes diagnosis (r=-0.30, 
p=0.016) compared to those who did not. Compared to women without the self-report of 
hypertension, those with hypertension had increased levels of EGF (r=0.28, p=0.027). Women 
with diabetes had higher levels of milk IL-4 compared to those who did not (r=0.27, p=0.031) 
and finally, women with one or more previous pregnancies had lower levels of milk MCP-1 than 
women with no previous pregnancies (r=-0.34, p=0.008) (see Table 21). 
Psychological Stressors. As self-perceived stress (PSS scores on Day 3 post-delivery) 
increased, there were statistically significant decreased levels of EGF, (r=-0.32, p=0.011), MIP-
1α (r= -0.25, p=0.048) and TNF-α (r= -0.27, p=0.034) (see Table 21).   
Environmental Stressors. As shown in Table 21, with the exception of relationship 
status, all of the environmental stressors studied were statistically significantly associated with 
levels of milk immune components on Day 3 post-delivery. Women who reported caring for 2 or 
more children had lower levels of MCP-1 (r= -0.26, p=0.042). Women who reported having 
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private insurance (a measure of socioeconomic status) had higher levels of EGF than did those 
with Medicaid or were self-pay (r=0.38, p=0.002). Mothers with Medicaid had higher levels of 
SIgA than did those with private insurance or were self-pay (r=0.32, p=0.012), while those 
reporting self-pay status had lower levels of milk SIgA than those mothers with private insurance 
or Medicaid (r= -0.30, p=0.022).  
Table 21: Day 3 Correlations of Maternal Stress Indicators with Milk Immune Components 
  SIgA EGF IL-10 IL-4 IL-6 IL-8 IP-10 MCP-1 MIP-1α TNF- α 
Age -0.03 
(0.829) 
0.23 
(0.075) 
-0.18 
(0.153) 
0.00 
(0.970) 
-0.01 
(0.946) 
-0.18 
(0.160) 
-0.15 
(0.242) 
-0.03 
(0.848) 
-0.17 
(0.195) 
-0.02 
(0.895) 
Pr  
Pg 
-0.14 
(0.279) 
-0.13 
(0.300) 
-0.19 
(0.139) 
-0.14 
(0.271) 
-0.17 
(0.171) 
-0.22 
(0.089) 
-0.13 
(0.295) 
-0.34 
(0.008) 
-0.22 
(0.084) 
-0.21 
(0.094) 
Del -0.10 
(0.432) 
-0.10 
(0.493) 
-0.16 
(0.198) 
0.06 
(0.624) 
-0.10 
(0.435) 
-0.12 
(0.371) 
-0.20 
(0.113) 
-0.18 
(0.164) 
0.05 
(0.725) 
-0.04 
(0.788) 
Smk               
Abx 0.20 
(0.133) 
-0.29 
(0.024) 
-0.13 
(0.317) 
0.03 
(0.789) 
0.11 
(0.401) 
0.02 
(0.890) 
-0.08 
(0.513) 
0.10 
(0.417) 
0.03 
(0.824) 
0.12 
(0.342) 
Hbp -0.13 
(0.340) 
0.28 
(0.027) 
-0.06 
(0.649) 
-0.07 
(0.599) 
-0.12 
(0.370) 
-0.05 
(0.693) 
-0.13 
(0.324) 
0.16 
(0.209) 
-0.05 
(0.725) 
0.06 
(0.636) 
Db 0.07 
(0.608) 
-0.30 
(0.016) 
-0.05 
(0.680) 
0.27 
(0.031) 
0.20 
(0.109) 
-0.03 
(0.823) 
-0.08 
(0.543) 
-0.01 
(0.929) 
0.13 
(0.324) 
-0.03 
(0.847) 
PSS -0.20 
(0.145) 
-0.32 
(0.011) 
-0.20 
(0.132) 
-0.03 
(0.807) 
-0.11 
(0.382) 
-0.22 
(0.080) 
0.06 
(0.624) 
-0.20 
(0.116) 
-0.25 
(0.048) 
-0.27 
(0.034) 
Ins -0.15 
(0.257) 
0.38 
(0.002) 
-0.13 
(0.323) 
-0.06 
(0.664) 
0.01 
(0.917) 
0.00 
(0.981) 
0.01 
(0.972) 
-0.02 
(0.861) 
-0.06 
(0.655) 
0.03 
(0.803) 
MC 0.32 
(0.012) 
-0.18 
(0.170) 
-0.01 
(0.962) 
-0.07 
(0.602) 
0.06 
(0.623) 
0.11 
(0.375) 
0.04 
(0.752) 
-0.08 
(0.555) 
0.12 
(0.332) 
0.06 
(0.642) 
Spy -0.30 
(0.022) 
-0.01 
(0.941) 
-0.09 
(0.509) 
-0.09 
(0.493) 
-0.16 
(0.226) 
-0.10 
(0.450) 
0.13 
(0.322) 
-0.10 
(0.431) 
-0.10 
(0.421) 
-0.15 
(0.240) 
#Ch -0.04 
(0.800) 
-0.25 
(0.053) 
-0.18 
(0.171) 
-0.23 
(0.074) 
-0.14 
(0.290) 
-0.17 
(0.188) 
-0.08 
(0.522) 
-0.26 
(0.042) 
-0.13 
(0.307) 
-0.10 
(0.451) 
Rel 0.01 
(0.970) 
0.17 
(0.177) 
0.11 
(0.409) 
-0.00 
(0.986) 
0.14 
(0.291) 
0.12 
(0.338) 
0.10 
(0.468) 
0.15 
(0.236) 
0.02 
(0.804) 
0.06 
(0.658) 
Note:  Values in the cells are r (p value); SIgA N=59, all others N=63, PrPrg= Previous Pregnancies (0=0, 
1≥1); Del=Mode of Delivery(1=Vaginal, 2=Cesarean Section); Smk= Smoking Status (0=No, 1=Yes); 
ABX= Received Antibiotics During Pregnancy(0=No, 1=Yes); Hbp= Hypertension (0=No, 1=Yes);  Db= 
Diabetes (0=No, 1=Yes); PSS- Summed Score of the Perceived Stress Scale; Ins= Private Insurance 
(0=No, 1=Yes); MC= Medicaid (0=No, 1=Yes); Spy= Self-Pay (0=No, 1=Yes); #Ch= Number of Children 
Under Care (1=1,2≥2); Rel= Relationship Status (0=Single, 1= Married/with Partner). 
Day 9  
The same inter-correlations among the maternal stressors (with the addition of salivary 
cortisol) and milk immune components on Day 9 post-delivery are shown in Table 22.  
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Physical Stressors. As was found on Day 3 post-delivery, on Day 9 women who had 
received antibiotics had lower levels of EGF (r=-0.24, p=0.038) compared to those women who 
had not received antibiotics. Also like Day 3, women with one or more previous pregnancies had 
lower levels of milk MCP-1 (r= -0.24, p=0.038) and in addition had lower levels of TNF-α (r= -0.31, 
p=.0.008) than women with no prior pregnancies (see Table 22).     
Psychological Stressors. There were no statistically significant relationships of maternal stressors 
with milk immune components observed on Day 9 (see Table 22).  
Environmental Stressors. At Day 9 post-delivery, rather than an association with MCP-1 (as seen 
at Day 3), women who reported caring for two or more children had lower levels of milk IL-6 (r=-0.26, 
p=0.028) and TNF-α (r=-0.31, p=0.008) than did women caring for fewer children.  
Salivary Cortisol. Salivary cortisol represents the overall biological response to all of the 
maternal stressors. The only statistically significant association of this marker with the milk immune 
components was with EGF. As levels of salivary cortisol increased, levels of EGF decreased (r= -0.32, 
p=0.006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 75 
 
Table 22: Day 9 Correlations of Maternal Stress Indicators with Milk Immune Components 
  SIgA EGF IL-10 IL-4 IL-6 IL-8 IP-10 MCP-1 MIP-1α TNF- α 
Age -0.07 
(0.584) 
0.13 
(0.280) 
-0.03 
(0.778) 
-0.08 
(0.505) 
-0.05 
(0.707) 
0.13 
(0.266) 
0.17 
(0.155) 
-0.02 
(0.865) 
0.10 
(0.429) 
-0.04 
(0.757) 
Pr 
Pg 
-0.11 
(0.373) 
0.03 
(0.822) 
-0.02 
(0.844) 
0.04 
(0.761) 
-0.17 
(0.156) 
0.02 
(0.899) 
-0.08 
(0.513) 
-0.24 
(0.038) 
-0.18 
(0.123) 
-0.31 
(0.008) 
Del -0.01 
(0.910) 
-0.13 
(0.267) 
-0.15 
(0.192) 
-0.17 
(0.163) 
-0.17 
(0.152) 
0.12 
(0.329) 
-0.13 
(0.276) 
-0.03 
(0.787) 
0.07 
(0.586) 
-0.10 
(0.456) 
Smk 0.10 
(0.529) 
-0.05 
(0.629) 
-0.01 
(0.932) 
-0.05 
(0.704) 
0.07 
(0.531) 
0.08 
(0.528) 
-0.07 
(0.534) 
0.14 
(0.246) 
0.07 
(0.546) 
0.10 
(0.438) 
Abx -0.10 
(0.393) 
-0.24 
(0.038) 
-0.20 
(0.106) 
-0.14 
(0.245) 
-0.01 
(0.914) 
0.10 
(0.407) 
-0.10 
(0.382) 
-0.11 
(0.376) 
0.04 
(0.735) 
-0.13 
(0.271) 
Hbp -0.02 
(0.853) 
0.02 
(0.893) 
-0.01 
(0.700) 
-0.01 
(0.702) 
-0.12 
(0.302) 
-0.03 
(0.837) 
-0.17 
(0.156) 
0.02 
(0.898) 
-0.02 
(0.864) 
-0.01 
(0.915) 
Db -0.14 
(0.248) 
-0.09 
(0.465) 
-0.11 
(0.343) 
-0.08 
(0.490) 
-0.12 
(0.311) 
0.03 
(0.808) 
-0.05 
(0.707) 
0.04 
(0.714) 
-0.08 
(0.517) 
-0.13 
(0.279) 
PSS -0.10 
(0.451) 
-0.09 
(0.322) 
-0.10 
(0.434) 
-0.03 
(0.828) 
0.12 
(0.919) 
0.18 
(0.139) 
0.08 
(0.557) 
-0.04 
(0.749) 
-0.02 
(0.868) 
-0.15 
(0.183) 
AUC 0.20 
(0.874) 
-0.32 
(0.006) 
-0.06 
(0.624) 
-0.16 
(0.183) 
0.04 
(0.763) 
0.08 
(0.490) 
0.08 
(0.525) 
-0.01 
(0.917) 
-0.02 
(0.877) 
-0.09 
(0.438) 
Ins 0.19 
(0.117) 
0.20 
(0.099) 
0.11 
(0.374) 
0.03 
(0.821) 
0.15 
(0.221) 
0.01 
(0.956) 
-0.06 
(0.640) 
0.18 
(0.118) 
0.15 
(0.193) 
0.13 
(0.292) 
MC -0.12 
(0.329) 
0.06 
(0.595) 
-0.20 
(0.093) 
-0.11 
(0.341) 
-0.21 
(0.081) 
-0.06 
(0.657) 
-0.08 
(0.512) 
-0.18 
(0.137) 
-0.15 
(0.195) 
-0.11 
(0.341) 
Spy -0.08 
(0.517) 
-0.06 
(0.659) 
0.02 
(0.888) 
-0.05 
(0.704) 
0.04 
(0.735) 
-0.20 
(0.892) 
0.01 
(0.965) 
0.03 
(0.787) 
-0.04 
(0.739) 
0.03 
(0.816) 
#Ch -0.17 
(0.162) 
-0.06 
(0.616) 
-0.21 
(0.073) 
-0.14 
(0.247) 
-0.26 
(0.028) 
-0.03 
(0.827) 
0.04 
(0.764) 
-0.20 
(0.090) 
-0.21 
(0.080) 
-0.31 
(0.008) 
Rel -0.06 
(0.624) 
-0.03 
(0.803) 
-0.07 
(0.587) 
-0.08 
(0.495) 
-0.04 
(0.737) 
0.02 
(0.938) 
-0.03 
(0.772) 
0.03 
(0.816) 
-0.04 
(0.764) 
-0.09 
(0.431) 
Note: Values in the cells are r ( p value); N=75; PrPrg= Previous Pregnancies (0=0, 1≥1); Del=Mode of 
Delivery(1=Vaginal, 2=Cesarean Section); Smk= Smoking Status (0=No, 1=Yes); ABX= Received 
Antibiotics During Pregnancy(0=No, 1=Yes); Hbp= Hypertension (0=No, 1=Yes);  Db= Diabetes (0=No, 
1=Yes); PSS- Summed Score of the Perceived Stress Scale; AUC= Salivary cortisol area under the curve; 
Ins= Private Insurance (0=No, 1=Yes); MC= Medicaid (0=No, 1=Yes); Spy= Self-Pay (0=No, 1=Yes); 
#Ch= Number of Children Under Care (1=1,2≥2); Rel= Relationship Status (0=Single, 1= Married/with 
Partner). 
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Day 14 
On Day 14 post-delivery, there were no statistically significant relationships of maternal 
stress indicators with milk immune components (see Table 23).   
Table 23: Day 14 Correlations of Maternal Stress Indicators with Milk Immune Components  
  SIgA EGF IL-10 IL-4 IL-6 IL-8 IP-10 MCP-1 MIP-1α TNF- α 
Age -0.06 
(0.637) 
-0.02 
(0.899) 
-0.11 
(0.370) 
-0.09 
(0.430) 
-0.01 
(0.929) 
-0.16 
(0.172) 
-0.06 
(0.617) 
-0.10 
(0.433) 
-0.16 
(0.182) 
0.03 
(0.816) 
Pr 
Pg 
-0.01 
(0.950) 
0.09 
(0.454) 
0.14 
(0.233) 
0.07 
(0.564) 
0.06 
(0.634) 
0.01 
(0.965) 
0.04 
(0.727) 
-0.12 
(0.302) 
0.07 
(0.563) 
-0.04 
(0.741) 
Del 0.01 
(0.952) 
-0.12 
(0.303) 
-0.04 
(0.717) 
-0.08 
(0.482) 
-0.09 
(0.445) 
0.02 
(0.843) 
-0.10 
(0.380) 
0.10 
(0.386) 
-0.13 
(0.291) 
-0.03 
(0.779) 
Smk -0.02 
(0.843) 
-0.02 
(0.839) 
-0.02 
(0.840) 
0.05 
(0.664) 
-0.01 
(0.958) 
0.02 
(0.863) 
-0.10 
(0.461) 
0.04 
(0.761) 
-0.01 
(0.906) 
0.01 
(0.911) 
Abx 0.01 
(0.941) 
-0.12 
(0.301) 
-0.12 
(0.312) 
-0.07 
(0.549) 
0.07 
(0.574) 
0.11 
(0.378) 
-0.10 
(0.386) 
0.10 
(0.406) 
0.09 
(0.454) 
-0.06 
(0.600) 
Hbp -0.05 
(0.673) 
-0.08 
(0.495) 
0.03 
(0.801) 
0.03 
(0.789) 
0.03 
(0.775) 
-0.07 
(0.564) 
-0.04 
(0.723) 
-0.07 
(0.582) 
-0.01 
(0.906) 
0.07 
(0.555) 
Db 0.05 
(0.683) 
-0.04 
(0.772) 
-0.12 
(0.306) 
-0.05 
(0.664) 
-0.14 
(0.231) 
-0.01 
(0.908) 
-0.17 
(0.161) 
-0.02 
(0.867) 
-0.11 
(0.371) 
-0.08 
(0.500) 
PSS 0.19 
(0.107) 
-0.02 
(0.884) 
0.03 
(0.815) 
0.02 
(0.902) 
0.07 
(0.540) 
0.23 
(0.054) 
0.07 
(0.547) 
0.09 
(0.437) 
0.11 
(0.350) 
-0.09 
(0.431) 
Ins 0.01 
(0.949) 
-0.16 
(0.166) 
0.04 
(0.758) 
0.01 
(0.960) 
-0.13 
(0.285) 
-0.15 
(0.220) 
-0.02 
(0.842) 
-0.08 
(0.511) 
-0.09 
(0.458) 
-0.12 
(0.300) 
MC -0.06 
(0.618) 
0.10 
(0.400) 
-0.01 
(0.948) 
-0.05 
(0.664) 
0.18 
(0.131) 
0.18 
(0.133) 
-0.05 
(0.684) 
0.11 
(0.348) 
0.15 
(0.207) 
0.21 
(0.078) 
Spy -0.18 
(0.129) 
-0.07 
(0.583) 
-0.06 
(0.613) 
-0.08 
(0.520) 
-0.12 
(0.310) 
0.15 
(0.214) 
0.05 
(0.683) 
-0.10 
(0.421) 
-0.05 
(0.689) 
-0.12 
(0.318) 
#Ch 0.02 
(0.867) 
0.16 
(0.376) 
-0.12 
(0.319) 
-0.07 
(0.581) 
-0.15 
(0.208) 
-0.06 
(0.640) 
0.04 
(0.766) 
-0.14 
(0.245) 
-0.03 
(0.807) 
-0.15 
(0.194) 
Rel 0.01 
(0.951) 
0.05 
(0.671) 
-0.04 
(0.737) 
-0.10 
(0.444) 
0.13 
(0.258) 
-0.14 
(0.233) 
0.01 
(0.933) 
0.10 
(0.425) 
0.10 
(0.396) 
0.14 
(0.250) 
Note: Values in the cells are r  (p value); N=73; PrPrg= Previous Pregnancies (0=0, 1≥1); Del=Mode of 
Delivery(1=Vaginal, 2=Cesarean Section); Smk= Smoking Status (0=No, 1=Yes); ABX= Received 
Antibiotics During Pregnancy(0=No, 1=Yes); Hbp= Hypertension (0=No, 1=Yes);  Db= Diabetes (0=No, 
1=Yes); PSS- Summed Score of the Perceived Stress Scale; Ins= Private Insurance (0=No, 1=Yes); MC= 
Medicaid (0=No, 1=Yes); Spy= Self-Pay (0=No, 1=Yes); #Ch= Number of Children Under Care 
(1=1,2≥2); Rel= Relationship Status (0=Single, 1= Married/with Partner).  
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Multivariate Associations of Stress Indicators with Milk Immune Components 
Using the model of maternal stress indicators there were no statistically significant 
multivariate associations with levels of any of the milk immune components on any day post-
delivery (see Table 24). 
Table 24:  Multiple Linear Regression of Maternal Stressors with Milk Immune Components by Day  
 Multiple R (Adjusted R
2
, p-value) 
Component Day 3 
N=63 
Day 9 
N=73 
Day 14 
N=73 
SIgA
a 
0.20 (-0.08,0.917)
 
0.25 (-0.2, 0.613) 0.20 (-0.05, 0.830) 
EGF 0.21 (-0.07, 0.896) 0.24 (-0.2, 0.640) 0.22 (-0.04, 0.773) 
IL-10 0.36 (0.02, 0.315) 0.37 (0.06, 0.104) 0.34 (0.03, 0.222) 
IL-4 0.35(0.01, 0.360) 0.30 (0.01, 0.340) 0.22 (-0.04, 0.759) 
IL-6 0.33 (0.04, 0.413) 0.29 (0.00, 0.409) 0.32 (0.02, 0.275) 
IL-8 0.20 (-0.07, 0.899) 0.26 (-0.02, 0.558) 0.34 (0.03, 0.226) 
IP-10 0.34 (0.01, 0.395) 0.28 (-0.00, 0.467) 0.16 (-0.06, 0.944) 
MCP-1 0.36 (0.02, 0.320) 0.31 (0.02, 0.303) 0.27 (-0.01, 0.514) 
MIP-1α 0.32 (-0.01, 0.482) 0.28 (-0.01, 0.471) 0.28 (-0.00, 0.466) 
TNF- α 0.36 (0.03, 0.295) 0.37 (0.06, 0.113) 0.31 (0.01, 0.388) 
Note: 
a 
= N of 59; Predictors- Mothers Age; Previous Pregnancies (0=0, 1≥1); Mode of Delivery 
(1=Vaginal, 2- Cesarean Section); Smoking (0=No, 1=Yes); PSS Day 3, 9, 14- Summed Score of 
Perceived Stress Scale; Medicaid (0=No, 1=Yes).   
 
Relationships of Stress Indicators with Salivary Cortisol 
Summaries of the correlations of each of the maternal stress indicators with salivary 
cortisol AUC values on Day 9 are shown in Table 25. None of these associations were 
statistically significant.  
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Table 25: Correlations of Maternal Stress Indicators with Cortisol AUC, N=73 
  AUC 
Age (Years) 0.11 (0.340) 
Previous  Pregnancy (0=0, 1≥1) 0.19 (0.119) 
Mode of Delivery (1= Vaginal, 2= Cesarean Section) 0.18 (0.134) 
Smoking (0= No, 1= Yes) 0.10 (0.398) 
Antibiotics Received During Pregnancy (0= No, 1= Yes) 0.10 (0.445) 
Hypertension (0=No, 1= Yes) -0.08 (0.488) 
Diabetes (0= No, 1= Yes) -0.00 (0.975) 
Private Insurance (0= No, 1= Yes) 0.00 (0.996) 
Medicaid (0= No, 1= Yes) -0.05 (0.679) 
Self-Pay (0= No, 1= Yes) 0.01 (0.969) 
Number of Children Under Care (1=1, 2≥2) -0.02 (0.890) 
Relationship Status (0=Single, 1= Married/Partner) 0.15 (0.219) 
Note: values in cells are r (p value). 
 
Cross-lagged Correlations of Maternal Stressors with Milk Immune Components 
Summaries of the cross lagged correlations of maternal stressors on Day 3 with milk 
immune components on Day 14 are shown in Table 26. All of the associations of maternal stress 
indicators with milk immune components were similar to those reported for Day 14 in Table 23 
except for self-perceived stress. Women with higher scores of self-perceived stress on Day 3 had 
higher levels of IL-8 on Day 14 post-delivery (r=0.26, p=0.025).   
Table 26: Correlations of Maternal Stress Indicators (Day 3) with Milk Immune Components 
(Day 14)  
  SIgA EGF 
 
IL-10 
 
IL-4 
 
IL-6 
 
IL-8 IP-10 
 
MCP-1 
 
MIP-1α 
 
TNF- α 
 
PSS 0.71 
(0.552) 
0.02 
(0.862) 
0.11 
(0.362) 
0.04 
(0.750) 
0.19 
(0.099) 
0.26 
(0.025) 
0.04 
(0.735) 
-0.01 
(0.907) 
0.22 
(0.060) 
-0.04 
(0.769) 
Note: Values in cells are r and p value; N=73; PSS- Summed Score of the Perceived Stress Scale.  
 
Associations of Stressors with the Change in Immune Components from Day 3-14 
Summaries of the association of stressors with the change in milk immune components 
are shown in Table 27. Women who received antibiotics had significantly less changes in the 
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levels of IL-10 from Day 3- Day 14 (r= -0.19, p=0.030) and those women who reported self-pay 
had greater changes in the levels of milk IL-8 from Day 3- Day 14 (r=0.15, p=0.040).  
Table 27: Correlations of Maternal Stress Indicators (Day 3) with Milk Immune Components 
Change (Day 3 to Day 14) Controlling for Baseline Milk Values (Day 3)  
  SIgA EGF 
 
IL-10 
 
IL-4 
 
IL-6 
 
IL-8 IP-10 
 
MCP-1 
 
MIP-1α 
 
TNF- α 
 
Age 0.07 
(0.352) 
-0.11 
(0.384) 
0.12 
(0.893) 
-0.14 
(0.225) 
0.06 
(0.529) 
-0.05 
(0.457) 
0.02 
(0.885) 
-0.03 
(0.813) 
-0.20 
(0.727) 
0.03 
(0.700) 
Pr 
Pg 
0.04 
(0.585) 
0.01 
(0.970) 
0.08 
(0.380) 
0.10 
(0.929) 
-0.08 
(0.363) 
0.00 
(0.992) 
0.10 
(0.434) 
-0.06 
(0.574) 
0.10 
(0.941) 
0.08 
(0.349) 
Del 0.02 
(0.758) 
-0.01 
(0.943) 
0.16 
(0.830) 
0.12 
(0.292) 
-0.06 
(0.544) 
-0.01 
(0.945) 
0.02 
(0.873) 
0.12 
(0.399) 
-0.02 
(0.826) 
-0.05 
(0.542) 
Smk                     
Abx -0.07 
(0.321) 
-0.04 
(0.740) 
-0.19 
(0.030) 
0.08 
(0.477) 
0.07 
(0.480) 
-0.3 
(0.743) 
0.05 
(0.728) 
-0.10 
(0.324) 
-0.01 
(0.890) 
-0.07 
(0.406) 
Hbp -0.05 
(0.464) 
-0.15 
(0.230) 
0.13 
(0.164) 
0.106 
(0.368) 
-0.02 
(0.848) 
-0.02 
(0.784) 
0.05 
(0.709) 
-0.03 
(0.774) 
0.03 
(0.658) 
-0.01 
(0.956) 
Db -0.01 
(0.843) 
0.09 
(0.473) 
0.00 
(0.963) 
0.09 
(0.470) 
-0.09 
(0.387) 
0.02 
(0.749) 
-0.04 
(0.781) 
0.02 
(0.840) 
0.03 
(0.676) 
-0.02 
(0.847) 
PSS 0.12 
(0.872) 
0.08 
(0.507) 
0.22 
(0.809) 
0.15 
(0.200) 
0.10 
(0.296) 
0.12 
(0.104) 
0.14 
(0.296) 
0.02 
(0.855) 
-0.02 
(0.741) 
-0.02 
(0.821) 
Ins 0.03 
(0.651) 
-0.05 
(0.723) 
-0.03 
(0.741) 
-0.01 
(0.951) 
-0.07 
(0.476) 
0.03 
(0.658) 
-0.04 
(0.764) 
0.08 
(0.473) 
-0.05 
(0.537) 
-0.10 
(0.256) 
MC -0.09 
(0.238) 
-0.01 
(0.913) 
0.10 
(0.263) 
0.07 
(0.542) 
0.05 
(0.612) 
0.03 
(0.682) 
-0.02 
(0.900) 
-0.00 
(0.988) 
0.06 
(0.353) 
0.15 
(0.091) 
Spy -0.10 
(0.179) 
-0.20 
(0.109) 
0.00 
(0.991) 
0.05 
(0.665) 
-0.10 
(0.294) 
0.15 
(0.040) 
0.02 
(0.868) 
-0.06 
(0.586) 
0.05 
(0.490) 
-0.04 
(0.622) 
#Ch 0.10 
(0.904) 
-0.01 
(0.952) 
-0.09 
(0.328) 
-0.01 
(0.892) 
-0.11 
(0.217) 
-0.04 
(0.559) 
0.07 
(0.585) 
-0.12 
(0.255) 
-0.03 
(0.615) 
0.10 
(0.908) 
Rel -0.02 
(0.732) 
-0.02 
(0.850) 
-0.06 
(0.490) 
0.02 
(0.894) 
0.15 
(0.103) 
-0.08 
(0.311) 
-0.06 
(0.629) 
0.07 
(0.600) 
0.04 
(0.761) 
0.14 
(0.317) 
Note: Values in cells are r (p value); N= [SIgA=48], [all others=51]; PrPrg= Previous Pregnancies (0=0, 
1≥1); Del=Mode of Delivery(1=Vaginal, 2=Cesarean Section); Smk= Smoking Status (0=No, 1=Yes); 
ABX= Received Antibiotics During Pregnancy(0=No, 1=Yes); Hbp= Hypertension (0=No, 1=Yes);  Db= 
Diabetes (0=No, 1=Yes); PSS- Summed Score of the Perceived Stress Scale; Ins= Private Insurance 
(0=No, 1=Yes); MC= Medicaid (0=No, 1=Yes); Spy= Self-Pay (0=No, 1=Yes); #Ch= Number of 
Children Under Care (1=1,2≥2); Rel= Relationship Status (0=Single, 1= Married/with Partner).  
 
Aim 2 
Assess the mediation (indirect) effect of maternal cortisol on the direct association of 
maternal stress indicators and milk immune components (antibodies, cytokines, and chemokines) 
from AA mothers of term infants.  
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As illustrated in Figure 5, summaries of the direct (C13) and indirect paths through 
salivary cortisol (A12) (B23) are summarized in Table 28. There were no statistically significant 
associations of cortisol with milk immune components (B23) after controlling for the correlation 
of PSS with the component (B23). Given that fact the adjusted associations of PSS with the milk 
immune components replicated the unadjusted associations seen in Table 26 (IL-8- beta=0.27, 
p=0.023 and MIP-1α- beta=0.24, p=0.046).    
Table 28: Direct and Indirect Associations Model 
 A12 
PSS-Cortisol 
B23  
Cortisol-Milk 
C13 
PSS-Milk 
Beta PSS Day 3 Milk Day14 
SIgA 
 
0.09 
(0.481) 
-0.08 
(0.511) 
0.03 
(0.781) 
0.04 
(0.748) 
EGF 
 
0.08 
(0.505) 
-0.06 
(0.651) 
0.02 
(0.904) 
0.02 
(0.876) 
IL-10 
 
0.08 
(0.505) 
-0.11 
(0.364) 
0.14 
(0.238) 
0.15 
(0.208) 
IL-4 
 
0.08 
(0.505) 
-0.15 
(0.225) 
0.09 
(0.450) 
0.10 
(0.395) 
IL-6 
 
0.08 
(0.505) 
-0.03 
(0.804) 
0.22 
(0.062) 
0.23 
(0.060) 
IL-8 
 
0.08 
(0.505) 
-.08 
(0.524) 
.27 
(0.026) 
0.27 
(0.023) 
IP-10 
 
0.08 
(0.505) 
-.19 
(0.107) 
0.03 
(0.824) 
0.04 
(0.721) 
MCP-1 
 
0.08 
(0.505) 
-0.11 
(0.381) 
-0.02 
(0.897) 
-0.01 
(0.953) 
MIP-1α 
 
0.08 
(0.505) 
-0.00 
(0.979) 
0.24 
(0.045) 
0.24 
(0.046) 
TNF-α 
 
0.08 
(0.505) 
-0.06 
(0.640) 
-0.03 
(0.841) 
-0.02 
(0.871) 
Note: Values in cells are beta (p value); N=70.  
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CHAPTER 5 
 
DISCUSSION 
 
Many of the maternal stress indicators in this sample of AA women mirrored those 
reported of all women in the US. The percentage of mothers that experienced vaginal birth and 
first time births in this sample were similar to 2010 national data of all women (vaginal births 
66% of live births; first time births- 40% of live births) (National Vital Statistics Reports, 2013).  
The use of antibiotics in this sample was slightly above national data which reports 27.9% of all 
women receive antibiotics during pregnancy (Centers for Disease Control and Prevention, 
2014a). However, the health characteristics such as smoking, hypertension and diabetes of this 
sample differed from the national health data of AA women. The national incidence of smoking 
(15.7%) and hypertension (19.2%) in AA women were greater than those self-reported in this 
sample, whereas diabetes (5.1%) among AA women was less than the reported percentage in this 
sample (Centers for Disease Control and Prevention, 2014b). Those mothers with Medicaid in 
this sample were reflective of all mothers with Medicaid (69%) in the state of Louisiana in 2010 
(U S Department of Health and Hospitals, 2010).  
The median values of salivary cortisol of AA women in this study were higher than those 
reported by Hampson and colleagues (2013) among women < 14 days post-partum 
(race/ethnicity not reported) (4.61± .03 ng/mL [95%CI=4.60,4.62]); however the timing of 
collections in this study used the cortisol awakening response (CAR-awake, 30 minutes post 
awake, 60 minutes post awake) while Hampson and colleagues used noon ± 2 hours (Hampson, 
Phillips, Soares, & Steiner, 2013).  
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The only stress indicator that changed over time (Day 3, 9, and 14) was self-perceived 
stress. Overall, the women in this study reported less perceived stress (PSS scores) across all 
study days than previously published PSS scores of women 4-6 weeks post-delivery 
(race/ethnicity not reported) (Mean= 21.3-27.7 [95%CI= 19.2, 29.8]). However, the PSS scores 
in this study did fall within the reported PSS score ranges of AAs in two cohorts from 2006 
(N=99, Mean=16.44 [95%CI=12.8, 20.1]), and 2009 (N=99, Mean=15.68 [95%CI=11.3, 20.1) 
(Cohen & Janicki-Deverts, 2012; Groer et al., 2005; Groer, 2005; Groer, Davis, & Steele, 2004). 
The internal reliability of the PSS item responses across all days also fell within previously 
published literature (Cohen, Kamarck, & Mermelstein, 1983; Nast, Bolten, Meinlschmidt, & 
Helhammer, 2013).  
The milk immune component values changed over time post-delivery as expected. 
Typically, the levels of immune components are higher in colostrum, then decrease as milk 
transitions to mature milk 7-10 days post-delivery (Agarwal et al., 2011). All of the immune 
components in this study decreased from Day 3- Day 14 except EGF which steadily increased. 
This finding differs from previous literature that described a decrease in this immune component 
over the first four weeks post-delivery (Castellote et al., 2011; Kumral et al., 2009).  There is a 
potential benefit of this finding if the increase in EGF is also found in future research for EGF 
promotes intestinal function and integrity which is essential for healthy infant growth and 
development. This study also adds to the literature by including chemokines (IP-10, MCP-1, 
MIP-1α) in the analyses for not much is yet known about these immune components.  
Over the past four decades, numerous studies have described associations of maternal 
stressors with milk immune components from mothers of term and preterm infants (Böttcher et 
al., 2008; Cruz et al., 1982; Ermis et al., 2009; Hawkes et al., 2002; Groer et al., 2004, 2005, 
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2009; Marek et al., 2009; O’Connor et al., 1998; Prokesova at al., 2006; Rigotti et al., 2006; 
Takahata et al., 2003; Thibeau & D’Apolito, 2012; Zanardo et al., 2007). This study adds to that 
body of knowledge by including maternal stressors that have not been previously reported in 
milk immune research such as diabetes, hypertension, antibiotics, number of children under care, 
and relationship status. The data suggests that the maternal stressors captured in this study were 
associated with levels of milk immune components during the first 14 days post-delivery.  Due to 
the descriptive design, no causality can be implied. However, the shared variance among the 
associations was frequently below 10% thus requiring caution in interpreting these results.  
In stress immune research, long-term stress is associated with an overall decrease in pro-
inflammatory immune responses, whereas short term stress is associated with an increased pro-
inflammatory immune response (Elenkov, 2004; Herbert & Cohen, 1993; Segerstrom & Miller, 
2004). The maternal stressors in this sample were associated with variations in pro-inflammatory 
and anti-inflammatory milk immune components, and an increase in milk antibodies. Figure 7 
illustrates these relationships: the bolded arrows represent significant relationships among 
maternal stressors with milk immune components on Day 3; the dashed arrows represent 
significant relationships on Day 9; and the dotted arrows represent significant relationships over 
time from Day 3- Day 14. All of the maternal stress indicators except for age, smoking, and 
relationship status were associated with levels of at least one of the milk immune components. 
Epidermal growth factor (EGF) had the most numerous significant relationships across time 
whereas there were no significant relationships observed for IP-10.  It is important to explore 
these finding for the relationships of maternal stress and milk immune protective components 
could potentially impact infant outcomes. 
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Figure 7: Matrix of Significant Relationships of Maternal Stressors with  
Milk Immune Components 
Note: Significant relationships were p values ≤ 0.050; Bolded arrows= simultaneous correlations  
on Day 3; Dash arrows= simultaneous correlations on Day 9; Dotted line arrows=cross-lagged 
correlations from Day 3-Day 14. 
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Changes in Milk Antibodies 
The antibodies in milk serve to instruct the newborn immune system to recognize and 
destroy pathogens as well as recognize healthy bacteria in the gut that are necessary for digestion 
(Brandtzaeg, 2003; 2010). The levels of milk antibodies such as SIgA are quite varied among 
women across the first 14 days post-delivery partially due to the mucosal associated lymphoid 
tissue pathway (MALT) (Brandtzaeg, 2003; 2010). The MALT pathway (appendix in large 
intestine, Peyers’s patches, tonsils and adenoids) is stimulated when a mother’s gastro-
intestinal/respiratory mucosal linings encounter pathogens in the environment (Brandtzaeg, 
2003, 2010). This stimulates an immune response in the mother to increase milk antibodies such 
as SIgA (Brandtzaeg, 2003; 2010).   
Only one maternal stressor, the environmental stressor of Medicaid status, was positively 
correlated with the milk antibody SIgA and this relationship was observed only on Day 3 (see 
Figure 8). Medicaid status is a measurement of lower socioeconomic status and is associated 
with negative maternal and infant outcomes (Marinda, Maxson, & Edwards, 2009; Ruiz & 
Avant, 2005; Elenkov, 2004). Medicaid status can be equated with poor living conditions which 
would logically increase the milk SIgA through the activation of the MALT pathway 
(Brandtzaeg, 2003, 2010). This relationship has previously been reported by Groer et al., in 2004 
where women of low income status had three times the levels of SIgA than women with higher 
income at 4-6 weeks post-delivery.  Although the levels of SIgA were not associated with any 
physical or psychological maternal stressors in this study, previous literature has reported  
decreased milk SIgA older women and increased milk SIgA in mothers with infections (Groer et 
al., 2004; 2005). That only one maternal stressor was associated with milk SIgA in this study 
could be a positive finding, meaning that the milk antibodies are not necessarily influenced by 
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maternal stress in the first 14 days post-delivery but further research is needed to clarify these 
findings.  
 
 
 
Figure 8: Significant Relationships of Maternal Stressors  
with Milk Antibodies 
Note: Bolded arrow= simultaneous correlations on Day 3. 
 
 
 
Changes in Pro-inflammatory Milk Immune Components 
The role of pro-inflammatory immune components in milk is to assist/instruct the naïve 
newborn immune system to mount a response to a pathogen (Field, 2005; Garofalo, 2010). 
Cytokines including chemokines are the messengers of the immune response, thus the C/C in 
milk direct other milk immune components as well as infant intestinal cells on the immune-
related mechanisms to destroy a pathogen (Field, 2005; Garofalo, 2010; Goldman, 2007).  
Although, there is known variations in the levels of milk pro-inflammatory C/C among women, 
it is not clear how much of the observed variations are associated with individual maternal 
characteristics/stressors (Agarwal, 2011; Thibeau & D'Apolito, 2012).  
In this sample, the levels of the pro-inflammatory C/C observed (IL-4, IL-6, IL-8, TNF-α, 
MIP-1α, MCP-1) were associated with maternal physical stressors (number of previous 
pregnancies and diabetes), psychological stressors (perceived stress), and environmental 
stressors (number of children under care) (see Figure 9).   The relevance of many of these 
observations to milk immune protective properties is not yet known. 
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Figure 9: Significant Relationships of Maternal Stressors  
with Milk Pro-inflammatory Immune Components 
Note: Bolded arrows= simultaneous correlations on Day 3, Dash arrows= simultaneous correlations on 
Day 9, Dotted line arrow=correlations from Day 3-Day 14.  
 
In the literature, maternal physical stressors such as the number of pregnancies and 
diabetes were associated with negative maternal infant outcomes such as preterm labor, large 
infant size for gestational age, risk factors contributing to delivery complications, and delayed 
milk production (Chida & Hammer, 2008; Finkelstein et al., 2013; Schwarz et al., 2010; 
Wendland et al., 2012).  Diabetes is considered an immune mediated disease, thus the underlying 
inflammatory process holds potential to alter the pro-inflammatory C/C levels in breastmilk 
(Chida & Hamer, 2008).  Women with diabetes in this sample had greater levels of milk IL-4 on 
Day 3 (see Figure 9) which has not been previously reported. There is one study that reported an 
increase of serum IL-4, IL-6, and IL-8  levels in overweight women with pre-diabetes (N=21) 
compared to matched controls (N=20), and a meta-analysis (N=19,709) reporting increased 
levels of serum IL-6 among diabetics (Lucas et al., 2013; Wang et al., 2013). Thus it could be 
plausible that in addition to seeing an increase in pro-inflammatory C/C in the blood among 
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women with diabetes there is also an increase in milk IL-4 especially in the early days of 
lactation (Day 3) where the tight junctions in the mammary epithelium may allow passage of 
serum C/C into milk. Further research would be needed to look at this association more closely 
especially since milk IL-4 is able to increase the production of milk antibodies which are needed 
for infant health and protection (Agarwal, 2011).   
One or more previous pregnancies was associated with decreased levels of milk TNF-α 
on Day 9 and MCP-1 on Day 3 and Day 9 (see Figure 9) which has not been previously reported. 
One or more pregnancies has been associated with negative maternal and infant outcomes 
(Lanier & Jonson-Reid, 2014). The number of pregnancies, particularly later in life has been 
attributed to oxidative stress in animals but there is controversy surrounding the conclusion of 
these studies (Speakman & Garratt, 2013). Oxidative stress releases toxic by-products that 
overtime may suppress immune function (Speakman & Garratt, 2013). In milk research, 
oxidative stress was suggested as the mechanism by which decreased milk TNF-α was observed 
among women who smoke (n=21) (Ermis, 2009). This relationship was not supported in this 
study. The decreased milk TNF-α observed on Day 9 in this study more than likely reflects the 
oxidative stress of the healing process of maternal tissues post-delivery. Previous research by 
Groer & Shelton (2009) reported a negative correlation of previous pregnancies with milk IL-10, 
an anti-inflammatory cytokine. This relationship was also not supported in this study. Further 
research is warranted to explore the inverse relationship of previous pregnancies and pro-
inflammatory cytokines such as milk TNF-α which regulate immune function within the infant 
intestinal cells (Field, 2005).  
Perceived stress, the psychological stressor captured in this study, was associated with 
decreased levels of milk TNF-α and MIP-1α on Day 3 and increased levels of IL-8 on Day 14 
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(see Figure 9). No previous research has reported these relationships in milk. Theoretically, acute 
perceived stress as measured in this study would be associated with an increase in pro-
inflammatory cytokines (Elenkov, 2004; Segerstrom & Miller, 2004). Recent research examining 
serum cytokine associations with perceived stress in pregnant women reported correlations with 
stress and depression. Depression was correlated with  decreased levels of serum TNF-α but the 
immune regulatory system during pregnancy is complex limiting comparisons to this sample of 
women post-delivery (Shelton, Schminkey, & Groer , 2014).  The bi-directional relationship of 
perceived stress with milk pro-inflammatory C/C in this study warrants further research for the 
implications of perceived stress altering the pro-inflammatory C/C in milk would have profound 
effects on infant health.  
The environmental stressor of the number of children under mothers’ care was inversely 
associated with MCP-1 on Day 3 and IL-6 and TNF-α on Day 9 (see Figure 9) which has not 
been previously reported. The increased number of children under mothers’ care could be 
considered similar to caregiver stress which is strongly correlated with the increased incidence of 
diseases of inflammation where pro-inflammation is predominant (Lovell  & Wetherell, 2011; 
Miller, Cohen, and Richey, 2002). In this study, the opposite was observed. One plausible 
explanation could be that immediately post-delivery many women receive an increased level of 
social support to welcome the newborn. This increased support may have buffered the pro-
inflammatory response to caregiver stress temporarily but more research is warranted to 
determine if these findings are generalizable.  
The overall observation of decreased pro-inflammatory milk immune component in 
association with physical, psychological and environmental stressors measured in this study 
makes an important contribution to science in that many of these stressors have not been 
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measured before in milk research and some of the findings contradict stress immune theory. 
Questions remain as to why both increased and decreased pro-inflammatory milk immune 
components were observed in relation to maternal stressors. Future research exploring the 
relationships among maternal stressors with serum and milk C/C in a larger sample would clarify 
whether milk pro-inflammatory immune components are associated with maternal stressors. Any 
changes in milk pro-inflammatory milk immune components would be relevant to infant health 
and important to understand.  
 
Changes in Anti-inflammatory Milk Immune Components 
The role of anti-inflammatory milk immune components in milk is to protect infant tissue 
injury from an immature exaggerated pro-inflammatory immune response (Field, 2005; 
Garofalo, 2005). The two anti-inflammatory milk immune components measured in this study, 
EGF and IL-10, were associated with the physical and psychological stressors but not the 
environmental stressors (see Figure 10). Both milk EGF and IL-10 function to improve the infant 
intestinal wall integrity which not only aids in developing the infant immature immune system 
but also prevents tissue damage from infant gastritis and/or necrotizing enterocolitis; the latter 
disease has a profound impact on infant morbidity and mortality (Agarwal, 2011; Chatterton, 
Nguyen,  Bering, & Sangild, 2013; Field, 2005; Fituch, Palkowetz, Goldman, Schanler, 2004; 
Nair, Warner, & Warner,  2008). Preliminary studies using EGF supplements administered to 
infants with necrotizing enterocolitis report intestinal repair (Chatterton et al, 2013; Nair et al., 
2008). Therefore it is important to understand if maternal stress is associated with alterations in 
the levels of either of these important anti-inflammatory immune components.  
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Figure 10: Significant Relationships of Maternal Stressors  
with Milk Anti- Inflammatory Immune Components 
Note: Bolded arrows= simultaneous correlations on Day 3, Dash arrows= simultaneous correlations on 
Day 9, Dotted line arrow=cross-lagged correlations from Day 3-Day 14.  
 
 The physical stressor infection as measured by the self report of receiving antibiotics 
during pregnancy was associated with decreased levels of EGF on Day 3 and Day 9 and 
decreased change in the levels of IL-10 from Day 3-Day 14 (see Figure 10). Although the use of 
antibiotics was higher in this sample than the national average usage during pregnancy, there was 
a measurement error in that the timing and frequency of the antibiotic usage was not part of data 
collections (Centers for Disease Control and Prevention, 2014a). Thus, the quantity of antibiotics 
received is not fully known in this sample. Antibiotics have both anti-microbial and anti-
inflammatory effects which are difficult to distinguish in relationship to the body’s immune 
response (Al- Banna et al., 2013). In a comprehensive literature review, the authors report that 
the toxins released when bacteria are destroyed from the anti-microbial actions of antibiotics 
there is an anti-inflammatory immune response stimulated (Al- Banna et al., 2013). This 
response can exhaust the release of anti-inflammatory cytokines such as IL-10 if the level of 
toxin by-products outweighs the anti-inflammatory immune response within the host (Al-Banna 
et al., 2013). This type of immune response would occur in extreme infections where the bacteria 
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massive toxin release from destroyed bacteria (Al-Banna et al., 2013). The mothers in this 
sample did not likely experience infections of this magnitude for they delivered at full term with 
no pregnancy complications. Thus the decreased change in the levels of milk IL-10 from Day 3- 
Day 14 in this study could be related to the increased release of anti-inflammatory milk 
cytokines if the antibiotics were administered close to the time of delivery but since the timing of 
antibiotics in not known, no conclusions can be made at this time. Likewise, the same holds true 
for the decrease in levels of milk EGF observed on Days 3 and 9. There is no prior report in the 
literature of these relationships therefore it is important that future research continues to explore 
the relationship of maternal antibiotic usage and the levels of pro-inflammatory C/C in milk.  
 The physical stressor hypertension is an immune mediated disease and is associated with 
negative maternal and infant outcomes as well as delayed milk production (Alevizos et al., 2014; 
Bramham et al., 2014; Calgani & Elenkov, 2006; Hurst, 2007). However, the role of serum EGF 
in hypertension is related to the increased vasoconstriction of the arterioles within the kidney and 
altered sodium absorption (Staruschenko, Palygin, Ilatovskaya, & Pavlov, 2013). The 
relationship of maternal hypertension with increased levels of milk EGF was not likely related to 
the role of EGF in hypertension but more related to the inflammatory processes of hypertension 
which would increase the need for anti-inflammatory cytokines. No previous milk research has 
explored this relationship. However, the low incidence of hypertension is this sample (n= 6) 
limits any generalizations of this finding but does indicate that future research is needed to 
further explore this relationship and the relevance to infant health.  
 The physical stressor diabetes was associated with decreased levels of EGF on Day 3 in 
this sample (see Figure 10) and has not been previously reported. In the literature, the absence of 
EGF receptors has been linked to reduced regeneration of pancreatic cells in animals and the 
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administration of EGF has been used to treat tissue damage related to diabetes (Tiaka, Papana, 
Manolakis, & Georgiadis, 2012). The women in this sample had diabetes prior to and during 
pregnancy but what was not captured was how their diabetes was being managed. In addition, 
the incidence of diabetes in this sample was low (n=6) which limits any conclusions. Future 
research is needed to explore this relationship with larger samples of diabetic women to 
determine if there is a relationship among women with diabetes and decreased milk EGF.    
Salivary cortisol is the biomarker of stress which reflects the physical response to all of 
the maternal stressors (physical, psychological and environmental); however, no one particular 
maternal stressor was significantly associated with salivary cortisol (see Tables 22, 25, and 28). 
The only milk component that was associated with salivary cortisol was EGF on Day 9, where 
decreased levels were observed (see Figure 10 and Table 22). This is the first such observation 
reported in the literature. In previous milk research conducted by Groer and colleagues (2004, 
2005), there were no statistically significant associations between serum cortisol and milk 
cytokines. It could be debated that the measurement of salivary cortisol on Day 9 post-delivery 
did not provide a sufficient enough wash out time period for the elevated levels of maternal 
serum cortisol associated with delivery (O’Keane et al., 2011). The cortisol levels in this sample 
were higher compared previous literature (Hampson et al., 2013). Serum cortisol is associated 
with decreased levels of serum pro-inflammatory C/C but this also was not observed in this study 
(Elenkov, 2004). Further research is needed to determine if these findings can be replicated. 
Finally, decreased levels of milk EGF was observed among women reporting increased 
perceived stress (PSS) on Day 3 post-delivery (see Figure 7). This is the first report of this 
relationship in the literature and there is no theoretical basis for this observation. More important 
to note, is that in this study milk EGF was influenced by more maternal stressors than any other 
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immune component and that influence extended through Day 9 post-delivery. This is a clinically 
significant finding that warrants future research given the fact that milk EGF is needed to 
promote the intestinal wall integrity of vulnerable infants experiencing gastritis or necrotizing 
enterocolitis and that supplemental oral administration of EGF has improved intestinal integrity 
in infants (Chatterton et al., 2013; Fituch et al., 2004; Nair et al., 2008). 
 
Cortisol as Mediator of Milk Immune Components 
In PNI theory, neurotransmitters such as cortisol are released during the activation of the 
HPA axis as a result of chronic stress (Elenkov, 2004, Segerstrom & Miller, 2004). Circulating 
cortisol influences the balance of the pro-inflammatory and the anti-inflammatory immune 
response. In the Post-Delivery Human Milk Model (see Figure 2), it was proposed that cortisol 
would mediate the direct associations of maternal stress indicators with milk immune 
components. The path of mediation proposed by Barron and Kinney (1986) is illustrated in 
Figure 11, the proposed Post-Delivery Human Milk Model variables are included in parentheses, 
and data from the mediation model in this study are reported next to the pathways. 
 
 
 
 
 
 
Figure 11: Mediation Model 
Note: Dashed arrows= non-significant correlations; Solid arrows- significant correlations.  
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 Assumptions for the mediating variable should include: (1) path a where the variations of 
the independent variable (maternal PSS) should be associated with variations in the mediator 
(cortisol); (2) path b where the variations in the mediator (cortisol) should be associated with 
variations in the outcome variable (milk immune components); and (3) when controlling for 
paths a and b, a stronger significant association should not be present on path c (Barron & 
Kinney, 1986). In this study, the independent variable (maternal PSS) was not significantly 
associated (p=0.481, 0.505) with the mediator cortisol (path a), and the associations of the 
independent variable of maternal PSS with the outcome variable of milk immune components 
(path c) were stronger than associations of the mediator cortisol with the outcome variable of 
milk immune components (path b) which were not significant (p=0.023, 0.024) (see Table 28 
and Figure 11).   
 One explanation of why cortisol was not a mediator in this model could be based on the 
theory that the majority of milk immune components arise from the mammary gland and milk 
cells instead of being transferred from maternal serum (Agarwal et al., 2011; Garofalo & 
Goldman, 1998). Results from this study provide supportive evidence that the majority of milk 
immune components (antibodies, cytokines, chemokines) arise from the mammary gland and 
milk cells as evidenced by the lack of significant associations of cortisol with milk immune 
components. This is an important finding for there is little evidence regarding the origins of milk 
immune cells but further research is needed to explore whether these findings are reliable and 
valid in larger more diverse samples of mothers of term infants.   
 Another explanation could be that the mothers in this sample reported lower PSS scores 
and lower cortisol than mothers in previous research on lactating women (Groer et al., 2004). 
The timing of collections could be one factor; in this study salivary cortisol was collected on Day 
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9 post-delivery whereas in the study by Groer (2004) serum cortisol was collected 4-6 weeks 
post-delivery. The later collection time period may better reflect the chronic care-giver stress and 
possibly the influence of returning to work or dealing financial constraints from not –working 
while on medical leave post-delivery.   
 
Conclusions 
Many of the relationships explored in this study are the first reported in the literature. 
There were significant relationships in nine out of the ten milk immune components measured 
with maternal stressors during the first 14 days post-delivery. Many of the milk immune 
component levels were not in the direction that would improve the immune protection of the 
infant. These findings suggest that the complexity of the variations in milk immune components 
reported in the literature to date may be related to maternal stressors not measured within those 
studies. As this study illustrates, physical, psychological and environmental stressors can 
influence the immune components of milk among healthy women delivering term infants. This 
information points to numerous questions yet to be explored. 
 
Strengths and Limitations 
 There are two important strengths to this study that warrant discussion; the longitudinal 
collections, and the population studied. By collecting milk over time, the findings of this study 
contributed to the knowledge of the natural variations in milk immune components and the 
directions of those variations could have clinical applications to infant health. Most noted, was 
the significant increase in the levels of milk EGF (see Table 20) even though maternal physical 
and psychological stressors were associated with lower milk EGF levels on Day 3 and 9 (see 
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Tables 21 and 22). The infant intestinal cell integrity is improved with milk EGF so this vital 
immune component is essential to infant health, particularly preterm infants. Knowing that even 
with maternal stress, the milk EGF levels continue to increase over time is a very positive 
finding. This information could be used to educate women that their milk protects their infant in 
many different circumstances and conditions.  
Regarding the population studied, this is the largest sample of milk collected from AA 
women reported in the literature to date. The levels of the milk immune components captured in 
this study fell within the existing published literature which largely represents White Caucasian 
women  in the US, Europe, and Eastern Europe. The findings of this study suggest that race is 
not likely associated with the known variations in milk immune components but rather the 
context of the mother’s individual situation (physical, psychological and environmental 
characteristics) may be more important.  Whether supportive interventions to decrease any 
negative characteristics in the mother’s individual situation will be positively associated with 
milk immune components is not yet known.   
Limitations of this study include the relatively small sample size, field collections of 
saliva and milk, and inconsistent measurements of some of the maternal stress variables. The few 
women meeting the inclusion criteria of breastfeeding initiation (38%) reflects the very low 
breastfeeding initiation rates of AA women here in Louisiana (Centers for Disease Control and 
Prevention, 2012a). The low breastfeeding duration rates among AA women in Louisiana were 
also reflected in this study sample. This attrition rate coupled with the lack of sufficient saliva 
and milk samples for analysis limited the number of complete data sets.   
Adequate field collections of the biological samples of saliva and milk were dependent 
on the adherence to collection and storage instructions. Although follow-up phone calls were 
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conducted by the study team to remind the participants of collection times and procedures, not all 
participants answered their phones. Reminders of instructions and contact information were left 
on voicemails but many voicemail boxes were full. Some mothers called back for clarification.  
Even though many samples were not sufficient for analysis, the reported values fell within 
existing literature.  
Confounding measurements of study variables decreased the validity of certain maternal 
stress indicators. For instance, the socioeconomic status choices listed were overlapping. In 
Louisiana, women eligible for Medicaid support are also eligible for lower cost private insurance 
adjunct policies so many of the participants in this sample checked both Medicaid and private 
insurance for socioeconomic status. The status of private insurance was blended and not 
completely reflective of socioeconomic status as intended. Another variable with confounding 
measurement was antibiotics received during pregnancy because there was no time period 
captured, thus no delineation when treatment with antibiotics occurred. Finally, the self-report of 
hypertension and diabetes were confounded with the fact that medications used to treat/control 
these conditions were not captured.  
To improve these limitations, the clarification on when the antibiotics were received, and 
the medications used for hypertension and diabetes would need to be collected. Providing home 
visits to assist with the collection, storage, and transportation of biological samples would likely 
increase the number of samples sufficient for analysis but home visits can be dangerous in this 
area of Louisiana. A safer alternative would be to capture samples on the days of clinic 
appointments for both the infant and the mother. The lessons learned in this study will be used in 
the design of future research of mothers of preterm infants.  
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Implications 
 While this study represents a beginning foundation of maternal stressors and milk 
immune components, it is a spring board for numerous future research questions. To determine if 
these findings are replicable, future studies should include larger sample sizes of women of 
diverse race/ethnicities across numerous geographic locations to explore the context of the 
maternal situations. Inclusion of serum as well as milk immune biomarkers and cortisol 
measurements pre and post-delivery would broaden the existing evidence of the immense 
variation of milk immune components and perhaps give insight to whether this variation is more 
sensitive to the maternal physical, psychological or environmental characteristics. 
Exploration of a weighted stress score for women post-delivery using the stress variables 
in this study would be beneficial to assess if there is an allostatic load adaptive stress response to 
the accumulated chronic stressors. Whether or not the allostatic load stress response is associated 
with levels of milk immune components would be important to explore. Targeted community 
interventions to improve maternal health holds potential to improve breastmilk immune 
protection and thus improve infant morbidity and mortality among vulnerable populations.  
Inclusion of mothers of preterm infants would be an important population to assess. 
Mothers of preterm infants are subject to more stress related to their birth experience, the 
underlying medical conditions that precipitate preterm delivery, and the emotional adjustments to 
the hospitalization of their preterm infant. Preterm infant mortality and survival are directly 
associated with the consumption of breastmilk, thus it would be important to explore whether 
milk immune components such as EGF were truly sensitive to maternal stressors that are 
particularly important to preterm infant morbidity and mortality.  
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Exploration of the role of the MALT pathway in relation to the amount of antibodies 
present in breastmilk would also be relevant to explore. A randomized control trial using skin to 
skin care as the intervention for mothers of hospitalized preterm infants to assess maternal stress 
and the MALT pathway immune response in milk would increase our knowledge of how the 
mothers’ immune system continues to interact with the environment to protect the infant. 
A factor analysis of the milk immune components at multiple time points post-delivery 
using a large sample of women in several different geographic locations would explore the co-
variation of these immune cells and how the immune cells influence function among other milk 
immune cells. This would lead to better understanding of how milk immunity is not stagnant but 
responsive to maternal situations.  
Lastly, in future research, it would be beneficial to include coping and social support 
measurements to explore whether the maternal perception of stress is buffered by coping and 
does this influence milk immune components and infant outcomes. An inter-disciplinary 
approach to design this research should include breastfeeding mothers themselves who could 
broaden the scope and depth of the contextual measurements of the experiences of these women.  
Due to the preliminary nature of these findings, there are no educational or clinical 
practice change recommendations at this time; however, the results will be disseminated in peer-
reviewed journals such as Biological Research in Nursing, Journal of Human Lactation, Journal 
of Perinatology, and Breastfeeding Medicine. Dissemination of the findings will enrich the 
existing science and point to new directions yet to be explored. Future research should continue 
to discover the mechanisms by which breastmilk immune protection evolves over time.  
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The decision to breastfeed will remain a personal one, but the science of milk immune 
protection should be made available to all women, especially those of AA descent, so they can 
make an informed decision about the initiation and duration of breastfeeding their infant.   
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Appendix A- Study Flyer 
 
There is a research study being conducted by Shelley Thibeau who is a graduate student at the 
Vanderbilt University School of Nursing.  
The purpose of the study is to explore the immune protection of breastmilk from African 
American women who deliver /term infants as well as the possible stress post- delivering a term 
infant. 
You are being asked to participate in the study because your milk is very important. Your milk 
contains not only nutrition to help your infant grow but many immune components that protect 
your infant against illness.  
If you agree to participate in the study, you will be asked to  
1. Provide a small sample of your milk (about one teaspoon) on Days 3, 9, and 14 post-
delivery 
2. Provide three saliva samples on Day  9 
3. Complete a short mothers survey about your pregnancy 
4. Complete 3 short surveys about yourself and any feelings of stress on each day of 
collection.  
The surveys should take about 10-15 minutes to complete.  
You will be provided with all the supplies you need to complete the surveys (paper, pen, 
envelopes), as well as supplies to collect and transfer the breastmilk.  
You will also be provided with a milk transport bag complete with ice-pack to bring your 
samples back to Shelley Thibeau at Ochsner Medical Center where they then will be shipped to a 
lab for analysis.  
The milk transport bag and ice-pack are yours to keep. 
Are you interested in being a part of this study? If yes, can you give us your contact information 
so that the study investigators may contact you to discuss the study and answer any of your 
questions? 
Thank You! 
If Yes:  Phone number and/or room number to contact you _____________________ 
If No: Thank you for your time 
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Appendix B: Consent 
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Appendix C: Mothers’ Survey 
 
Please answer the following:  
1. What is your current age?   _______ 
Circle all that apply: 
2. American Indian or Alaska Native 
 Asian 
 Black or African American 
 Native Hawaiian or Other Pacific Islander 
 White      
3. Number of previous pregnancies: _______ 
4. Number of previous preterm deliveries: _____ 
5. Number of living children under your care: _____                Yes          No 
6. Did you have high blood pressure with this pregnancy? 
7. Do you still have high blood pressure post-delivery?      
8. Did you have diabetes with this pregnancy?                    
9. Do you still have diabetes post-delivery?                         
10. Did you have asthma during this pregnancy?                   
11. Do you still have asthma post-delivery?                           
12. Did you receive steroids during this pregnancy?              
13. Do you smoke?                                                                              
14. Were you given antibiotics during this pregnancy?                      
15. What is your current relationship status? 
__   Single 
__   Married 
__   In a relationship with a partner 
 
16. Circle all of the following methods of payment apply to you: 
__  Private insurance 
__  Medicaid 
__  Self-pay 
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Appendix D: Perceived Stress Scale 
 
Questions Never   Almost 
Never   
Some-
times 
Fairly 
Often     
Very 
Often 
1. In the last few days, how often have you 
been upset because of something that 
happened unexpectedly? 
 
2. In the last few days, how often have you 
felt that you were unable to control the 
important things in your life? 
 
3. In the last few days, how often have you 
felt nervous and “stressed”? 
 
4. In the last few days, how often have you 
dealt successfully with day to day 
problems and annoyances? 
 
5. In the last few days, how often have you 
felt that you were effectively coping 
with important changes that were 
occurring in your life? 
 
6. In the last few days, how often have you 
felt confident about your ability to 
handle your personal problems? 
 
7. In the last few days, how often have you 
felt that things were going your way? 
 
8. In the last few days, how often have you 
found that you could not cope with all 
the things that you had to do? 
 
9. In the last few days, how often have you 
been able to control irritations in your 
life? 
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10. In the last few days, how often have you 
felt that you were on top of things? 
 
 
11. In the last few days, how often have you 
been angered because of things that 
happened that were outside of your 
control? 
 
12. In the last few days, how often have you 
found yourself thinking about things 
that you have to accomplish? 
 
13. In the last few days, how often have you 
been able to control the way you spend 
your time? 
 
14. In the last few days, how often have you 
felt difficulties were piling up so high 
that you could not overcome them? 
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Appendix E: Maternal- Infant Data Collection Sheet 
 
Study ID___________________                        Date enrolled__________________ 
1. Gender:        Male ____   Female ____ 
2. Birth Weight: _________     grams 
3. Gestational Age:________ weeks 
4. Length of Stay: __________days 
5. Infant Demise if applicable:  __________Day Post-Delivery  
6. Maternal HbA1c if mother is diabetic: _________Use last recorded in medical record. 
7. Maternal blood pressure: ____________Use last recorded in medical record post-delivery.  
8. Volume human milk feedings per day  
9. Day 3: _____________ Number of times infant breastfed or breast pumped 
10. Day 9: _____________ Number of times infant breastfed or breast pumped   
11. Day 14: ____________ Number of times infant breastfed or breast pumped  
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Appendix F: Salivary Collection Instructions 
 
Please do the following on Day 9 post-delivery: 
1. Do not eat or drink anything 30 minutes prior to saliva collection 
 
2. Upon awakening on Day 9 post-delivery 
a. Wash hands and rinse mouth out with cold water. 
b. Obtain study container for cortisol labeled with study 
ID/day of collection. 
 
3. Follow the directions provided below for collection 
a. Remove the top cap of the tube to expose the round 
sponge.  
b. Do not remove the holder that the sponge is sitting in.  
 
 
 
c. Place the sponge directly into your mouth by tipping the 
tube so the sponge falls into your mouth.  Do not touch 
the sponge with your fingers.  
 
 
 
d. Keep the sponge in your mouth.  Very gently chew and 
roll the sponge around in your mouth for 2 minutes.  Spit 
the sponge back into the tube.  Do not touch the sponge 
with your fingers. 
e. Replace the cap.  Make sure cap is on tightly. 
f. Place pre-labeled study tube in refrigerator. 
4. Repeat steps 1-3, 30 minutes after the first collection on Day9. 
5. Repeat steps 1-3, 60 minutes after the first collection on Day9. 
*** If at any time you are having trouble getting enough saliva- chew one piece of sugarless gum 
for 10 minutes to make more saliva. Remove gum from mouth before collecting saliva. 
 
 
Transporting study containers to Shelley Thibeau at Ochsner Medical Center: 
1. You may use the milk transport bag to bring the frozen saliva containers along with your 
milk.  
2. Study containers of saliva should be packed in the provided milk transport bag with 
frozen ice-packs to keep the saliva cold.   
3. DO NOT USE ICE CUBES (WET ICE) TO TRANSPORT FROZEN SAMPLES. A 
clean towel can be used to fill any extra space between containers. 
 
For any questions please call: Shelley Thibeau: 504.616.5557 
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Appendix G: General Instruction Sheet for Mother Participants 
 
Please do the following when you first get home: 
1. When you get home please take out the ice pack within the Medela Human Milk transfer bag and 
place it in your freezer. 
2. At your earliest convenience please fill out the Mothers’ Survey (should take less than 5 minutes), 
place in designated envelope.  
Please do the following every day:  
1. Shower daily. 
2. Wear a clean bra each day and wash daily in warm soapy water. 
3. Change wet or moist breast pads frequently.  Moist pads can promote growth of germs. 
4. Wash your hands thoroughly with soap and water for 15 seconds before pumping or handling your 
milk.  
5. If you will be using an electronic pump, assemble the pump collection kit and have ready the sterile 
milk container. Place these items on a clean surface next to the breast pump. 
6. Each time after you have finished pumping using the electronic pump, take apart all of the parts of the 
breast pump collection kit.  Be sure to remove the yellow valve from the breast shield and separate 
the white membrane from the yellow valve.  Rinse all of these parts with cool water then wash with 
warm soapy water. Rinse off the soapy water with cool water and air dry on a clean towel covered 
with a clean cloth.  All parts may also be washed after each use in the top rack of a dishwasher. 
7. Once each day, sterilize all of the parts of the breast pump collection kit.  This can be done by boiling 
the kit parts for 10 minutes or by using a Quick Clean Micro-Steam Bag made by Medela, Inc in the 
microwave. 
8. Notify your baby’s nurse or doctor if you become ill or need to take any medication, even over-the-
counter medicines. 
On Day 3________ please do the following: 
1. At the first or second feeding of the morning, hand express or pump your breasts using an electric 
pump. Pour 1 teaspoon (5 mL) into the study container with study label Day 3. Store milk sample in 
the freezer. 
2. Fill out the Perceived Stress Scale (should take about 5 minutes). 
On Day 9________please do the following: 
1. At the first or second feeding of the morning, hand express or pump both breasts using an electric 
pump. Pour 1 teaspoon (5 mL) into the study container with study label Day 9. Store milk sample in 
the freezer.  
2. Fill out the Perceived Stress Scale (should take about 5 minutes). 
3. Collect saliva upon awakening, 30 minutes and 60 minutes after awakening using the Salivary 
Collection Instruction Sheet. Store saliva samples in a refrigerator  
On Day 14__________ please do the following: 
1. At the first or second feeding of the morning, hand express or pump both breasts using an electric 
pump. Pour 1 teaspoon (5 mL) into study container with study label Day 14. Store milk sample in the 
freezer. 
2. Fill out the Perceived Stress Scale (should take about 5 minutes). 
***All of the milk and saliva samples and surveys can be delivered to Shelley Thibeau at Ochsner 
Medical Center. You will receive a $25.00 gift card when all three milk and saliva samples as well as 
surveys are received. If you have any questions please contact Shelley Thibeau: 504.616.5557 or 
shelley.thibeau@vanderbilt.edu or sthibeau@ochsner.org . 
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Appendix H: Training Manual for Study-Staff 
 
1. Study staff must complete the CITI course on Human Participant Protection in accordance with 
their respective institutions prior to data collection. 
2. Study staff must agree to the following: 
a. Be available during their normal work hours to address any of the mothers/staff 
questions/concerns related to the study. 
b. Be available during their normal work hours to consent participants. 
c. Assist the PI with data collection the Maternal Infant Data Collection Sheet 
d. Be available for weekly conference calls with the PI to summarize participant enrollment, 
any problems obtaining data and/or collection of milk samples and surveys. 
3. The PI will provide each study site coordinator with the following: 
a. 24/7 contact information 
b. Participant packets to include:  
i. The general instruction sheet with the milk collection, storage, and handling 
instructions for three small milk collection containers with study ID labels, three 
salivette kit and instructions for salivary cortisol collection , one paper copy of 
the Mothers’ Survey, three copies of the Perceived Stress Scale, all mothers will 
receive four envelopes with study ID labels, one pen, a milk transport bag with 
icepack, and microwave sterilization kit for pumping supplies   
4. Algorithm for study participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
Mother seen on routine lactation visit and consented 
to study by study site coordinator/PI 
Mother receives research packet with supplies 
for survey completion and sample collection 
Day3 
MTI will complete the 
Mothers Survey, the PSS, 
and collect and store milk 
sample 
Day 9 
MTI will complete the PSS.  
Collect and store saliva and 
milk sample 
Day 14 
MTI will complete the 
PSS and collect and 
store milk sample 
All mothers will transport saliva and milk samples using milk transport bag 
and deliver to Shelley Thibeau at Ochsner Medical Center 
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